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ABSTRACT 
An individual infected with HIV may have no visible symptoms of the illness. 
Therefore, it is important for individuals who are sexually active to practice self-
protective behaviors (e.g. discussing HIV testing with potential sex partners). The current 
descriptive study assessed the self-protective behavior of obtaining an HIV-antibody test 
within the framework of The Health Belief Model (HBM). Perceptions regarding 
susceptibility to HIV infection, severity of the disease, benefits or barriers to HIV-
antibody testing, and personal self-efficacy for engaging in protective behaviors were 
assessed in “Testers” (those who have been tested for HIV infection) and “Non-testers” 
(those who have not been tested). Phase 1 of the current study validated the HIV Testing 
Attitude Scale (HTAS) using introductory psychology students and clients from the 
county health department (n=203). Six items not included on the original HTAS reached 
significance with correlations ranging from 0.39 to 0.52 and were added to the scale. In 
Phase 2, participants (n=362) recruited from three health facilities and introductory 
psychology students were assessed using the HTAS, Self Efficacy Scale, Health Locus of 
Control, AIDS Health Belief Scale, Social Desirability, and specific items measuring 
attitudes and perceptions towards self-protective behaviors. Significant differences 
between Testers and Non-testers were found in HTAS, SES, HLOC, AHBS, SD, age, 
education level, drug or alcohol use associated with sexual activity, age of first coitus, 
knowledge of self-protective behaviors, and perception of personal susceptibility. 
Limitations of the HBM to differentiate between those who have and those who have not 
been tested for HIV infection were discussed along with limitations of the current study 
and suggestions for future research. 
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INTRODUCTION 
One of the biggest public health concerns we face in the United States today is 
Acquired Immune Deficiency Syndrome (AIDS). Since the beginning of the AIDS 
epidemic in the early 1980’s, the Centers for Disease Control and Prevention (CDC) has 
reported 831,112 cases of AIDS in the United States (Figure 1) and estimates that there 
are over 1 million cases of Human Immunodeficiency Virus (HIV) infection (CDC, 
2003). HIV, the virus that causes AIDS, attacks and weakens the immune system of its 
host, causing him or her to become susceptible to innumerable opportunistic infections, 
which ultimately prove fatal. HIV is transmitted via very specific avenues of contact with 
contaminated body fluids (e.g. blood, semen, vaginal secretions, or human breast milk). 
While there is no cure or vaccine for HIV infection or AIDS at this time, there have been 
effective treatments available since the mid-90’s to bolster and maintain the immune 
system of individuals infected with HIV (CDC, 1998). Commonly referred to as HAART 
(highly active antiretroviral therapy) or a “drug cocktail”, the treatments are combinations 
of protease inhibitors and transcriptase inhibitors (Henkel, 1999), which interfere with the 
virus’ ability to enter, reproduce or exit the host cell.. 
As with any virus, the consequences of HIV infection depend upon the ability of 
the immune system of its host to fight it off. During the initial stages of infection, 
individuals infected with HIV can look and feel healthy with no physical symptoms to 
suggest that they may be a health hazard to anyone with whom they come in specific 
contact (CDC, 1998). This latency period, which can last an average of seven years 
(CDC, 1998), is a challenge not only for health practitioners, but for health educators as 
well. 
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Figure 1. Number of AIDS Cases Reported by the CDC Through 2002 
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Prior to the onset of symptoms, the only way to determine that someone may be 
infected with the HIV virus is by obtaining a blood test, which screens specifically for the 
HIV-antibody. The HIV antibody test is an enzyme immunoassay (EIA) blood test that 
screens for antibodies created by the host’s body as a response to the presence of the HIV 
virus (CDC, 1997). The EIA test is highly accurate and is followed by a confirmatory test 
to guard against the risk of a “false positive” test result (CDC, 1997). A positive HIV-
antibody test only tells if a person is infected with HIV, it does not tell when the person 
was infected or when he or she will develop an opportunistic infection and be diagnosed 
with AIDS.  
As with any illness or medical condition, the earlier the disorder is detected the 
better, and this holds true for HIV infection. Early detection of HIV serves two purposes. 
First, with the availability of effective treatments such as protease inhibitors and 
transcriptase inhibitors (Henkel, 1999), early medical intervention for HIV infection leads 
to improved health, which can result in a longer latency period. Second, early 
identification of the virus can lead to a decrease in the spread of the virus via an increase 
in preventive behaviors, and ultimately a reduction in the population incidence of HIV 
infection. 
However, how is someone who feels fine and looks healthy convinced to engage 
in self-protective behaviors? Early education and prevention efforts regarding AIDS and 
HIV were largely information based and focused on risk education. The assumption of 
this approach was that a greater understanding of the behaviors associated with HIV 
transmission would result in an increase in HIV preventive behaviors (DiClemente, 
1994). However, research does not support the idea that increased knowledge necessarily 
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leads to a behavior change (Baldwin & Whitley, 1990; Brafford & Beck, 1991; Jemmott, 
Jemmott, & Fong, 1992). In fact, research suggests that many individuals mistakenly 
believe that they are able to choose uninfected potential sex partners based upon their 
look of apparent health (Agocha & Cooper, 1999). 
In addition to the dissemination of correct information regarding HIV and AIDS, 
there are specific behaviors routinely suggested for sexually active individuals to practice 
in order to guard against HIV infection via sexual intercourse. While these behaviors are 
commonly known as “safer sex,” a more inclusive term may be self-protective or 
preventive behaviors as the list encompasses more than just sexual behaviors.  
Self-protective behaviors include discussing sexual history with potential sex 
partners, negotiating the use of condoms with sex partners, refusing sexual intercourse 
without condoms, abstaining from alcohol or drug use before or during sex, having an 
HIV-antibody test, and discussing HIV-antibody testing with potential sex partners 
(Bandura, 1992). While much research has been conducted regarding the preventive 
behavior of condom use (e.g. Albarracin, Fishbein, Middlestadt, 1998; Basen-Enquist & 
Parcel, 1992; Brafford & Beck, 1991; Brien, Thombs, & Mahoney, 1994; Bruce, Shrum, 
Trefethen, & Slovik, 1990; Caron, Davis, Wynn, & Roberts, 1992; Henrich, 1993; 
Mahoney, Thombs, Ford, 1995), limited research has been done regarding the self-
protective behavior of obtaining an HIV-antibody test (Anastasi, Sawyer, & Pinciaro, 
1999; Goodman, Chesney, Tipton, 1995; Miller, Hennessy, Wendell, Webber, 
Schoenbaum, 1996; Rothman, Kelly, Weinstein, O’Leary, 1999; Wilson, Jaccard, 
Minkoff, 1999). 
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At particular risk for HIV exposure, and therefore infection, are adolescents. 
Adolescence is a time of increased risk of exposure to HIV due to increased sexual 
activity with a greater potential for multiple sex partners (Brafford & Beck, 1991). In 
fact, Basen-Enquist and Parcel (1992) found that by the age of 17, 57% of adolescents in 
an urban setting reported being sexually active, and of those 15-24 year olds who were 
sexually active, only 20% reported any condom use at all. Consequently, the rationale for 
focusing on older adolescents aged 18-24 with respect to HIV and AIDS is two-fold. 
First, adolescents are engaging in behaviors that put them at risk for exposure to HIV and 
other sexually transmitted infections. Second, accounting for the latency period of HIV, 
the majority of 25-29 year olds currently infected with HIV at this time were most likely 
infected while they were adolescents.  
Theoretical Perspective 
Many theoretical approaches have been used in HIV and AIDS prevention 
research. The Theory of Reasoned Action (Fishbein, Middlestadt, Hitchcock, 1994), 
Theory of Planned Behavior (Ajzen & Madden, 1986), Information-Motivation-Behavior 
Model (Fisher & Fisher, 1992; Fisher, Fisher, Misovich, Kimble, Malloy, 1996), AIDS 
Risk Reduction Model (Catania & Kregels, 1990), and the Health Belief Model 
(Rosenstock, Stretche, & Becker, 1988) have been used to try and understand why some 
people engage in HIV self-protective behaviors while others do not. These theories have 
overlapping constructs related to attitudes, beliefs, and intentions, which have been 
assessed to understand behavior, specifically self-protective behavior. While some of the 
theories focus on long-term behavior change, others assess short-range behavioral issues. 
The Health Belief Model is theory that has historically been used to assess screening or 
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preventive behaviors and will be used as a framework in this study. 
Health Belief Model 
The Health Belief Model (HBM) was developed in the 1950’s to explain the 
public’s failure to participate in screening programs to detect tuberculosis (TB) 
(Rosenstock, Stretcher & Becker, 1994). While there were numerous screening sites set 
up for individuals to obtain screening X-rays, few individuals actually took advantage of 
these opportunities. The HBM was the resulting theory that helped explain this lack of 
participation in preventive behaviors. The public’s reaction to the TB health crisis during 
the 1950’s is alarming in its resemblance to the HIV/AIDS epidemic today. Individuals 
who were at risk for TB were able explain lack of participation in prevention via 
perceptions about the disease and personal susceptibility, time constraints, finances, fear 
of the procedure, or other barriers to the behavior (Rosenstock et al., 1994). Today, there 
are many opportunities for individuals to participate in HIV preventive behaviors, 
specifically obtaining an HIV-antibody test. However, statistics show that few individuals 
actually participate in HIV screening opportunities (Kalichman & Hunter, 1993). 
Consequently, the tenets of the HBM may prove particularly well suited to the 
assessment of this HIV preventive behavior and understanding the lack of public 
participation. 
The HBM posits that in order for a behavior change to occur, three factors 
regarding health-related action must be present. An individual must feel threatened by 
his/her current behavior, believe that a specific change in behavior will be beneficial by 
resulting in a valued outcome at an acceptable cost, and must feel that she or he is 
competent to implement the recommended change (Rosenstock et al., 1988). These 
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components are particularly salient when dealing with HIV infection. Specifically, a 
person must feel that there is a realistic, not just statistical, probability of contracting HIV 
as a result of his or her current behavior. There may be individuals who are at risk for 
HIV infection who simply do not perceive themselves to be at risk because they are not  
members of groups that have been disproportionately affected by HIV and AIDS, such as 
gay men or IV drug users. However, the CDC reports indicate that HIV infection via 
heterosexual contact is on the rise for men and women (Table 1; CDC, 2003).  
Thus, the HBM takes an individual’s past experience and characteristics into 
account as a pre-existing component of the model. An individual’s perceptions of a 
specific disease are founded in an individual’s background and allow for assessment of 
issues salient to that individual. Figure 2 provides a summary of the components of the 
HBM (Rosenstock et al., 1994). Perceived susceptibility refers to a person’s perception of 
his or her risk of becoming infected with HIV. Perceived severity of the disease gauges 
feelings regarding the seriousness of AIDS. Taken together, perceived susceptibility and 
severity account for a person’s perception of the threat of HIV infection or AIDS. 
Perceived benefit indicates a person’s beliefs regarding the efficacy of the self-protective 
behavior. Perceived barriers refer to an individual’s perception of the negative aspects of 
the self-protective behavior. Cues to action account for internal and external events that 
trigger performance of the behavior, in this case obtaining an HIV-antibody test. Finally, 
self-efficacy refers to a person’s beliefs regarding his or her ability to successfully obtain 
an HIV-antibody test.  
Rosenstock and colleagues (1994) suggested that everyone may not perceive 
personal threat in the same way. Some may have a “sequential assessment” and only  
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Table 1.      
      
Cumulative Cases of HIV Reported by the CDC Through 1999 by Exposure Type 
            
      
Exposure Category1 Male Female Total 
            
      
Men who have sex with men 36823 (45) 0 36823 (33) 
      
Individuals who inject drugs 11678 (14) 6390 (21) 18068 (16) 
      
Men who have sex with men  5139 (6) 0 5139 (5) 
and inject drugs    
      
Heterosexual contact: 5407 (7) 12151 (40) 17558 (16) 
      
 Sex with an injecting drug user 1232 3,547 4,779 
      
 Sex with a bisexual male 0 936 936 
      
 
Sex with a person with 
hemophilia 14 108 122 
      
 Sex with transfusion recipient 81 92 173 
 with HIV infection    
      
 Sex with HIV-infected person; 4080 7,468 11,548 
 risk unspecified    
      
Hemophilia/coagulation disorder 436 (1) 18 (<1) 454 (<1) 
      
Recipient of blood transfusion/tissue 350 (<1) 375 (1) 725 (1) 
      
Other/risk not reported or identified 21850 (27) 11377 (38) 33236 (30) 
      
  Total 81683 (100) 30311 (100) 112003 (100) 
            
      
Note: Table information is given in frequency(percent)   
      
1 - Exposure category refers to the specific type of exposure reported by an individual who  
      
has tested positive for HIV    
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Figure 2.  Schematic Representation of the Components of the Health Belief Model   
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subjective threshold. Consequently, if perceived severity is low, then personal 
susceptibility would never actually be considered. However, if perceived severity of 
AIDS is high, then personal susceptibility is assessed and whether or not to perform self-
protective behaviors (i.e., have an HIV-antibody test) is considered.  Under a state of 
high-perceived severity, perceived susceptibility will be a stronger predictor of intent to 
engage in self-protective behaviors rather than a predictor of actually engaging in  
preventive behaviors (Rosenstock et al., 1994). This is due to the fact that other issues, 
addressed by other components of the HBM, such as self-efficacy, will become salient 
and determine whether or not the individual will follow through on the perception of 
threat. 
The other process suggested by Rosenstock and colleagues (1994) for assessing 
perceived threat is “multiplicative assessment”, by which both perceived susceptibility 
and perceived severity are considered simultaneously and multiplied together. The 
resulting amount helps the individual make a decision about whether or not to engage in 
the appropriate behavior. Specifically, multiplicative assessments influence the way an 
individual processes risk-based prevention messages. If perceived susceptibility and 
perceived severity of the disease are both high, chances of engaging in self-protective 
behaviors are also high. However, if either perceived susceptibility or perceived severity 
is sufficiently low, then perceived threat is also low, as are chances of the individual 
engaging in the behaviors (Rosenstock et al., 1994). 
Past research assessing the components of the health belief model with sexuality 
or HIV-related issues have generally focused on the self-protective behavior of condom 
use rather than HIV-antibody testing, and generally on college students as participants. In 
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a study investigating attitudes about AIDS, homosexuality and condoms among college 
students, Bruce et al. (1990) found mixed results regarding the utility of the Health Belief 
Model to understand AIDS related behavior. Although participants in the study reported 
believing AIDS to be a severe illness and that condom use can help prevent the spread of 
HIV infection, they did not perceive themselves as susceptible to AIDS nor did they feel 
compelled by environmental cues to change their behavior (e.g. condom use).  
Similarly, Basen-Enquist (1992) used components from the Health Belief Model 
(perceived susceptibility and perceived barriers to behavior change), Social Learning 
Theory, the Theory of Reasoned Action, and theories of cognitive coping style to 
investigate predictors of “safer sex” in a college population. Regression analysis showed 
that perceived susceptibility was significantly related to increased intention to use 
condoms while perceived barriers were significantly related to decrease in actual as well 
as intended condom use (Basen-Enquist, 1992).   
Mahoney, et al. (1995) tested the ability of components of the Health Belief 
Model (perceived susceptibility, perceived benefits, and perceived barriers), self-efficacy, 
and other “behavioral” and demographic variables to distinguish between three groups of 
condom users (nonusers, sporadic users, and consistent users) among college students. By 
using principal components analysis, Mahoney et al. (1995) found that perceived 
susceptibility and perceived barriers are multidimensional constructs. Perceived 
susceptibility reliably broke down into two factors: perceived susceptibility–partner and 
perceived susceptibility–self. Four factors emerged from perceived barriers: turnoffs, 
hassles, execution, and relationship concerns. While the variables of the study showed 
mixed results in the ability to discriminate between the three types of condom users, the 
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components of the health belief model used were moderately able to distinguish between 
the three groups of condom users, and were most effective at discriminating sporadic 
condom users (Mahoney et al., 1995).  
Thus, the components of the Health Belief Model have had mixed success in 
prediction of condom use. Unfortunately, there is limited published research available 
assessing the components of HBM with the protective behavior of obtaining an HIV-
antibody test. However, the addition of mastery or self-efficacy as a component of the 
Health Belief Model may improve its usefulness as a framework by which to investigate 
preventive behaviors, specifically HIV-antibody testing decisions. 
Self-Efficacy 
Initially, the Health Belief Model did not include self-efficacy as a component as 
the model was originally used to explain preventive actions, primarily screening visits, 
which were seen as requiring little ability on the part of the individual (Rosenstock et al., 
1988).  However, once the HBM was applied to chronic illnesses that required long-term 
health-related behavior change, self-efficacy, as a component of the HBM, helped 
account for the initiation and maintenance of behavioral change (Bandura, 1994) which 
would not have been accounted for by the HBM without self-efficacy. 
As a separate construct, self-efficacy has received much attention in the research 
of HIV-related issues. Specifically, self-efficacy states that given appropriate skill and 
adequate incentive, efficacy expectations are major determinants of an individual’s 
choice of behavior, amount of effort he or she will exert, and how long he or she will 
persist in difficult situations (Bandura, 1977). The components of self-efficacy are level, 
generality, and strength. Level indicates a person’s expected performance attainment. 
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Generality refers to the notion of global vs. specific efficacy. Global efficacy, indicating 
the number of areas in which a person sees themselves as capable, can be seen as an 
individual’s overall or comprehensive feeling of competence or ability, while specific 
efficacy refers to the competence a person feels within a specific domain or situation. 
Strength applies to the confidence a person has that once having attained a certain level, 
and then, after attaining that level, move on to a higher or more difficult level (Bandura, 
1977). 
According to Bandura (1994), an individual’s belief in his or her personal efficacy 
to exercise control over and regulate his or her own sexual behavior plays a crucial role in 
whether or not the idea of changing risky behavior will be considered. In other words, if 
an individual does not have control over his or her own behavior, there is little motivation 
to even try to change that behavior. Within the framework of self-efficacy, there are four 
interactive components of self-directed change for self-protective behaviors: information, 
personal determinants, behavior, and environment (Bandura, 1994). 
Though it may seem quite obvious, in order to increase self-protective behaviors, 
individuals need to have knowledge of what those behaviors actually are. By increasing 
the public’s awareness and knowledge of health risks associated with not practicing 
preventive behaviors, they may be prompted to examine their own behavior. Once the 
idea of susceptibility to HIV infection has become incorporated at the personal level, the 
focus is on development of self-regulative skills to translate concern or fear into self-
protective behavior. For an individual to become efficacious at any skill, it must be 
practiced and guided with corrective feedback (Bandura, 1992). Finally, the individual 
must have a support group, which approves of and encourages the desired behavior 
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change. Although the ability to persevere and succeed in the face of difficult and 
challenging circumstances is an indication of high self-efficacy (Forsyth & Carey, 1998), 
initially, the behavior changes must be reinforced and encouraged to increase the 
probability of maintenance of the behaviors (Bandura, 1994). 
Wulfert & Wan (1993) also reported the importance of peer comparison by 
developing a “Self-efficacy Model of Safer Sex”. They found that self-efficacy mediates 
sexual attitudes, condom outcome expectancies, peer comparison, and perceived 
vulnerability. Specifically, sexual attitudes referred to an individual’s attitude or opinion 
regarding condoms. While individuals may think condom use is a good idea, they tend to 
forget about using condoms when highly aroused (Wulfert & Wan, 1993). Positive 
condom outcome expectancies enhanced an individual’s self-efficacy, while negative 
outcome expectancies reduced self-efficacy. People form beliefs about their own 
capabilities by comparing themselves to others who are similar and by observing how 
they behave. Finally, knowledge alone does not motivate behavior change but may act as 
cue to heighten perceived vulnerability. People integrate knowledge, outcome 
expectancies, emotional states, social influences and past experiences to judge their 
ability to master a situation (Wulfert & Wan, 1993). 
Brien et al. (1994) found that condom use self-efficacy accounted for differences 
between three groups of condom users (nonusers, sporadic users, and ritualistic users). In 
addition, through factor analysis of the underlying dimensions of the condom use self-
efficacy scale developed by Brafford & Beck (1991), Brien et al (1994) found that 
condom-use efficacy is multidimensional. Four factors were identified: mechanics, 
partner’s disapproval, assertive, and intoxicants. While mechanics (a person’s confidence 
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in their skill), and intoxicants (a person’s confidence in their ability and skill while 
intoxicated) do not directly apply to the behavior of obtaining an HIV-antibody test, the 
other two dimensions seem quite pertinent. Partner’s disapproval and the ability to deal 
with rejection regarding the discussion about and request for a partner to have an HIV-
antibody test, as well as the perceived anxiety of requiring a potential sex partner to have 
an HIV-antibody test, and the possibility of having to refuse to have sexual intercourse if 
not, seem to fit perceived barriers to the self-protective behavior of HIV-antibody testing. 
In other HIV-related research considering the construct of self-efficacy, Brafford 
& Beck (1991) found that condom use self-efficacy is a predictor of condom use among 
college students. Basen-Enquist & Parcel (1992) found self-efficacy to be a predictor of 
safer sex behaviors among ninth graders, and Henrich (1993) found self-efficacy is a 
predictor of contraception among college women. 
HIV-antibody Testing 
Although condom use is the most commonly researched self-protective behavior, 
the focus of this study is on HIV-antibody testing, specifically, the decision to obtain a 
test. It is only recently that researchers have begun to look at the issue of HIV-antibody 
testing as a preventive behavior. Though some researchers may not have consciously set 
out to test components of the health belief model, we can find support for the application 
of HBM to HIV-antibody testing in their results.  
Anastasi, Sawyer, and Pinciaro (1999) conducted a descriptive study to develop a 
profile of students requesting an HIV-antibody test at a student health center. While the 
study provided information regarding the demographics of those students requesting 
HIV-antibody testing, more pertinent to the present study is the list of perceived benefits 
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of HIV-antibody testing reported by the participants. The three most commonly reported 
reasons for HIV-antibody testing reported by the participants were:  “I just want to know 
if I’m infected” at 69.6%, “I had recent unprotected sex with someone whose HIV status 
I’m unsure about” at 51.0%, and “I have just begun or plan to begin a sexual 
relationship” at 37.9% (Anastasi et al., 1999). Anastasi and colleagues  (1999) also noted 
that some of the barriers to obtaining an HIV-antibody test are the negative impact of 
discussing HIV testing with a partner and the stress of waiting for the test results. Also of 
interest was the participant’s reported level of susceptibility based on sexual behavior 
over the previous 6 months. Even though only 41.5% of the participants reported condom 
use, 88% of the participants rated their likelihood of contracting HIV as “low” (Anastasi 
et al., 1999). 
One of the problems associated with using a convenience sample of college 
students is the generalizability of the research. Wilson et al. (1999) dealt with this issue 
by testing family planning patients with ages ranging from 15 to 45 at three different 
clinic sites in an urban setting. Participants were initially assessed regarding their attitude 
toward HIV-antibody testing by a series of questionnaires. During the course of the 
study, participants were given the opportunity to obtain the HIV-antibody test or decline. 
At the time a participant declined to be tested, she was interviewed regarding the specific 
reasons. Although 75% of all participants reported positive attitudes or felt favorably 
about taking an HIV-antibody test, when given an opportunity to have the HIV-antibody 
test, only 7% of the women actually tested. The most common reasons were time 
constraints (56%), plan to test another time (13%), and being too anxious about the  
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results (9%). Less than 2% had recently been tested or did not perceive themselves as 
susceptible to HIV.  
Two predictors regarding HIV-antibody testing were identified were identified by 
Wilson et al. (1999). If a participant felt that she would learn that it was “too late” for 
treatment, she was less likely to obtain the HIV-antibody test, which can be classified as 
a barrier to getting an HIV test. Conversely, if a participant felt that the results of the 
HIV-antibody test would help her plan a pregnancy, which the HBM model would 
classify as a benefit of obtaining an HIV-antibody test, she was more likely to have the 
HIV test. 
In their study, Wilson and colleagues (1999) noted that the actual percentage of 
participants who declined HIV-antibody testing due to anxiety may in fact be a larger 
proportion than the 9% indicated by the data. This suggestion is based on two facts. First, 
the study was conducted while the participants were at a previously scheduled clinic visit. 
At the time appointments were made, patients at these clinic sites were routinely 
instructed to allot approximately 2 hours for their appointment. Participation in the study 
did not increase or decrease the amount of time for the participant’s clinic appointment. 
Second, at a follow-up of clinic records, none of the participants who said they would 
return at a later date to be tested had actually done so (Wilson et al., 1999). It may be that 
telling the researcher that they did not have time to be tested or would be tested another 
day was for some reason a more acceptable response for the participants than admitting 
anxiety regarding the HIV test.  
A common theme in the research at this point indicates that a barrier to obtaining 
an HIV-antibody test has to do with anxiety regarding the results. However, Conley, 
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Taylor, Kemeny, Cole, & Visscher (1999), did not find this in their Multicenter AIDS 
Cohort Study (MACS) research conducted in the mid to late 1980’s with homosexual 
men in San Francisco. In fact, they found that anxiety about AIDS is not reduced by 
avoiding knowing HIV status. Moreover, avoidance appears to create a psychological 
state equivalent to assuming oneself to be HIV-positive. 
In order to take part in the MACS study, participants had to have an HIV-
antibody test, but they did not have to learn the results. As part of the MACS study, 
participants had a physical check-up every 6 months and completed a variety of 
psychological assessments, at which time those participants who were not aware of their 
HIV status were given an opportunity to learn the results of their test. Some participants 
chose not to learn their HIV status for as long as 5 years after testing and only learned 
their status at that point due to the development of drug protocols for non-symptomatic 
HIV-positive individuals.  
Results of the psychological scales administered indicate that individuals who 
were unaware of their HIV status: 1) had just as many thought intrusions about AIDS and 
worries that physical symptoms may be the onset of AIDS, 2) saw themselves as being as 
high a risk for developing AIDS, and 3) had the same levels of mood disturbances and 
hopelessness scores as individuals who actually were HIV-positive (Conley et al., 1999). 
As individuals in the MACS study who chose not to learn their HIV status functioned at 
levels of agitation as high as individuals who knew they were HIV-positive, anxiety 
appears to be a psychologically ineffective barrier for obtaining an HIV-antibody test. 
While the gay male population used in the MACS study may seem quite different than 
the adolescent heterosexual population considered in this study, they have similar 
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concerns. Although cues for obtaining an HIV-antibody test may be different, the anxiety 
and fear associated with testing and the implications of the test results are relevant issues 
for the heterosexual population as well (Anastasi et al., 1999; Wilson et al., 1999). 
In other HIV-antibody testing research, Goodman et al. (1995) used the Scheier 
Life Optimism Test to assess the extent to which optimism, knowledge, attitudes, and 
beliefs predicted HIV-antibody testing among adolescent females with a history of risky 
sexual behaviors, but were unable to determine any significant predictors of HIV-
antibody testing. Rothman et al. (1995) assessed the saliency of susceptibility brought on 
by watching a video about HIV-positive individuals who were similar to the college 
participants as a predictor of intention to get an HIV-antibody test. They found that the 
strongest predictors of intention to get an HIV-antibody test were: 1) depression after 
watching the video, 2) concerns about past behavior, and 3) perceptions of current risk 
for HIV. Finally, Miller et al, (1996) offered voluntary HIV-antibody testing to 
adolescents as part of a visit to a clinic in an urban setting and found two behavioral 
predictors of accepting the HIV-antibody test: history of multiple sex partners and no 
condom use within the last year.  
In another vein of HIV-antibody testing research, Boshamer & Bruce (1999) 
developed a measurement tool specifically for assessing attitudes towards HIV-antibody 
testing. Developed using a convenience sample of heterosexual college students, the HIV 
Testing Attitudes Scale (HTAS) shows four factors: concerns about friend’s responses, 
concerns about family’s responses, beliefs about public opinion, and concerns about 
confidentiality. As such, the HTAS assesses attitudes towards testing as well as helps 
identify perceived barriers and benefits to obtaining an HIV-antibody test.  
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Purpose and Hypotheses 
 The purpose of Phase 1 of the current study was to administer the HTAS to a 
sample of college and non-college students to examine its generalizability in use with a 
non-college sample. In Phase 2, the components of the Health Belief Model were used to 
compare individuals who have had an HIV-antibody test (Tester) and those who have not 
had an HIV-antibody test (Non-tester) at two local health facilities and in a college 
population. In addition to obtaining descriptive information, this study investigated the 
validity of the HBM in terms differentiating individuals who have had an HIV-antibody 
test (Testers) from those who have not been tested (Non-testers).  
As predicted by the HBM, it was hypothesized that that there were would be 
differences between Testers and Non-testers in perceived benefits and barriers to HIV 
testing, self-efficacy, and perceived threat but not for perceived severity. Specifically, I 
hypothesized that Testers would:  a) have more positive attitudes toward HIV-antibody 
testing, b) have an greater perception of personal susceptibility to HIV, c) see more 
benefits and fewer barriers to obtaining an HIV test, d) have a more internal locus of 
control over health in general, and e) have a higher self-efficacy score regarding the self-
protective behaviors of discussing condom use and HIV-antibody testing with potential 
sexual partners. In addition, I hypothesized Testers would report routine practice of other 
self-protective behaviors (e.g. little drug/alcohol use associated with sexual activity, 
consistent condom use, fewer sex partners). I hypothesized these differences would exist 
even after accounting for other sample differences such as gender, age, and location. 
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PHASE 1 
Method 
Participants 
 The participants for Phase 1 were recruited from two sources: the STD clinic at 
the New Hanover County Health Department (n=116) and the introductory psychology  
student subject pool undergraduate (n=113). The reported sexual behavior of the sample 
was largely heterosexual (male=90% and female=85%), thus the number of self-reported 
homosexual participants was too small to assess their data as a separate group. To avoid 
possible confounds, the data from participants who indicated a sexual preference other 
than exclusively heterosexual were deleted from the sample. Data for 17 health 
department participants and 10 subject pool students were deleted due to incomplete data 
or sexual preference. The data for the remaining 99 health department and 103 subject 
pool participants were used to validate the HIV Testing Attitude Scale.  
As previously stated, the sample used for the development of the HTAS measure 
was a convenience sample of introductory psychology students originally surveyed in 
1995 (Boshamer & Bruce, 1999). Table 2 shows a comparison of the characteristics of 
the Boshamer & Bruce (1999) sample and the current (2000) sample populations. It is 
important to note differences that exist between the original sample and either of the 
current research samples of introductory psychology students or health department 
clients. There are similarities between the student samples in mean age, racial/ethnic 
composition. However, in the current sample, there was a greater percentage of male 
respondents, students scores on the HIV Testing Attitude Scale suggested the students 
held a less favorable attitude toward HIV-antibody testing, fewer students reported  
 
 
22
Table 2.     
    
Comparison of 1999 and 2000 Samples Represented as Frequency (Percent) 
        
    
Variables 1999 Students4 HD4 
        
    
Sample n  150 103 99 
    
HIV Testing Attitude Scale1 71.9(11.2) 68.5(8.9) 74.2(12.0)
    
Current Age2 20.0(3.1) 20.0(4.3) 26.7(7.5) 
    
Age Range 17-37 16-57 18-48 
    
Male 48(31%) 48(47%)5 60(61%)6 
    
Female 108(69) 55(53) 39(39) 
    
Caucasian 135(87) 90(87) 59(60)6 
    
Know someone with HIV or AIDS 50(32) 17(17)5 34(34)6 
    
Sexually Active 137(91) 82(82)5 98(99)6 
    
Unplanned pregnancy - 11(11) 41(43)6 
    
Treated for an STD - 9(9) 42(42)6 
    
Had HIV-antibody test - 26(26) 90(91)6 
    
Know someone who is gay, lesbian, 
bisexual - 88(85) 70(71)6 
        
    
1 - HTAS: Means(SD), 1-100 scale; higher scores equal more favorable attitude toward HIV testing 
    
2 - Age presented as Mean (Standard Deviation)    
    
3 - Values taken from Boshamer & Bruce (1999)    
    
4 - Student and Health Department clients are from the 2000 sample  
    
5 - 1999 and 2000 student samples differ significantly for all Χ2 (p < 0.05)  
    
6 - Student and HD samples differ significantly for all Χ2 (p < 0.05)   
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knowing someone with HIV or AIDS, and fewer students indicated they were sexually 
active. In addition, there were differences between the original student sample when 
compared to the health department sample across each variable assessed, which affects 
the comparison to the overall data as well.  
Procedure 
To validate the HTAS (Boshamer & Bruce, 1999) for use with a clinic population, 
the original preliminary scale of 82 questions (Appendix A) was administered to 
participants from the STD clinic at the New Hanover County Health Department and the 
undergraduate psychology student subject pool over a 3-month period. All introductory 
psychology students were recruited via departmental protocols and received class credit 
for participation. Clients from the health department were approached individually 
regarding participation and were also compensated for participation. Each clinic 
participant who completed the 82–item questionnaire was entered in a raffle for $50 to be 
held at the end of the research project.  
Before starting to collect data at the Health Department, a formal request was 
made to the Director of Communicable Diseases at the New Hanover County Health 
Department requesting permission. After approval was received (Appendix B), a meeting 
was held with the reception and clinic staff to develop a process that would allow 
researchers to have access to clients but would not violate patient confidentiality nor 
impede the clinic flow. As a result of this meeting, the following procedure was 
implemented: After clinic patients checked-in with the clinic receptionist, those who were 
eligible to participate in the study were called to a private room individually by the 
researcher. At this time, the research was presented as a study about the general public’s 
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opinions about HIV and STD testing, and the client was offered the option of 
participating. Clients who agreed to participate were given a clipboard with the 
questionnaires attached and shown to a seating area separate from the main waiting room; 
those who declined returned to the waiting area. In order to avoid any undue influence 
that the interview with the clinic counselor or educator may have on the clinic 
participant’s responses to the scale questions, the clinic patients completed the HTAS and 
self-efficacy scales prior to being seen by the clinic educator. In order that participant’s 
appointment time could be maintained, once these two questionnaires had been 
completed, the patient was able to take the clipboard with him or her during the clinic 
visit and continue to work on the remaining survey information. The participant returned 
the questionnaires to the researcher or clinic counselor when they were completed. 
In addition to the HIV-antibody testing attitude scale, each participant completed 
a series of demographic questions regarding age, gender, education, and race, as well as 
questions assessing other variables which may be related to HIV-antibody testing. The 
wording for these variables was adjusted to be appropriate for the specific sample. For 
example, students were asked their year in school while health department clients were 
asked their level of education (Appendix C). Additionally, some of the questions used in 
Phase 2 of this study were piloted at this time for readability. These questions included 
information about HIV risk, attitudes toward people with HIV/AIDS, HIV-antibody 
testing history, likelihood of being tested in the future, perception of personal 
susceptibility and self-efficacy regarding self-protective behaviors (Appendix D). 
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Results 
Originally, the plan was to develop a tool with which to assess internal and 
external cues to HIV-antibody testing as a pilot during Phase 1. Unfortunately, many 
participants simply left this section of the questionnaire blank. Of the participants who 
did complete these questions, there was very little variability in responses given as 
advantages or disadvantages to obtaining an HIV test. Consequently, due to the lack of 
responses and diminished variability of responses gathered, this tool was not developed. 
Items on the original 82-item questionnaire (Boshamer & Bruce, 1999) were 
determined by a panel of experts in the area of AIDS education and HIV prevention to be 
either a facilitator or barrier attitude to HIV-antibody testing. A facilitator item was 
defined as being “pro-HIV antibody testing” and a barrier as being “con-HIV antibody 
testing”. For example, agreement with a statement that family or friends would support 
the decision to have an HIV-antibody test would be considered a facilitator to having an 
HIV-antibody test, while disagreement with the same statement would represent a barrier 
to having a test. 
 Each attitude item on the scales was scored on a 5-point Likert scale ranging from 
1 (strongly disagree) to 5 (strongly agree). Following the scoring patterns of Boshamer 
and Bruce (1999), responses on the HTAS were scored so higher scores corresponded 
with a favorable attitude towards HIV-antibody testing. For responses to facilitators of 
HIV-antibody testing, strong agreement was scored a 5 and strong disagreement was 
scored a 1. Responses to barriers to HIV-antibody testing were reverse scored such that 
strong agreement with these items was scored as a 1 and strong disagreement was scored 
as a 5. Finally, all scores were converted to a 0 (con) to 100 (pro) scale and interpreted 
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using the equation:  25(∑x-N)/N, where ∑x equals the sum of the scores and N equals the 
number of items on the HTAS.  
 The data obtained from the clinic and subject pool samples were then analyzed 
separately using corrected item-total correlation. In this analysis, each individual item is 
correlated with the total scores (minus the score for that particular item). This yields 
information about which items are most strongly related to overall favorable or 
unfavorable attitudes regarding HIV-antibody testing. Only items with significant 
positive correlations are reserved for the final scale, and any item that does not correlate 
significantly is eliminated. Using an adjusted per comparison error rate of p < 0.0006 
(Bonferroni correction), any item not significant at this alpha level was discarded.  
 Thirty-nine items out of the original 82 items were significant for the STD clinic 
sample with corrected item-total correlations ranging from 0.38 to 0.62; 38 of the original 
82 items were significant for the subject pool participants with corrected item-total 
correlations ranging from 0.38 to 0.54. Significant items for all samples were then 
compared to the 32-item final version of the HTAS (Boshamer & Bruce, 1999). There 
were six items that were significant for both clinic and student samples that were not 
included on the HTAS (Boshamer & Bruce, 1999) scale, and nine items on the HTAS 
(Boshamer & Bruce, 1999) 32-item scale that did not reach significance for one or both 
of the current (2000) samples. However, four of these nine items approached significance 
with corrected item-total correlations ranging from 0.34 to 0.37. The six significant and 
nine non-significant items included both barriers and facilitators to HIV-antibody testing.   
Because the health department participants may not have completed the HTAS 
questionnaire before meeting with the clinic counselor and going through the HIV and 
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STD educational session, there could be a source of added error in the health department 
data. Additionally, there could be further error in the overall sample due to differences 
between the health department and subject pool data on variables such as age, gender, or 
location when completing the questionnaire. Consequently, the original 32-item HTAS 
scale was preserved in its existing order and the six items that were significant for both 
samples were added to the end of the questionnaire (Table 3). 
The similarity in responses between the original and the 2000 student samples seems to 
point to the continued validity of the HTAS as a measure of attitudes regarding HIV-
antibody testing for a student population. Additionally, while the demographics for the 
health department participants differ significantly from the student samples, similarity in 
significant items between the two samples supports a generalized use of the HTAS. 
PHASE 2 
Method 
 Participants 
In Phase 2 of the current study, participants were recruited from the introductory 
psychology student subject pool, the Student Health Center (SHC), Wilmington Health  
Access for Teens (WHAT), and the New Hanover County Health Department 
(HD). As in Phase 1, data were deleted for participants who indicated a sexual preference 
other than exclusively heterosexual, reported no previous sexual activity, or did not 
complete the surveys in their entirety. 
 Students. Originally, the students from the two campus locations were to be 
analyzed as separate samples. However, there were too few male testers at either location 
to conduct appropriate statistical analyses. Consequently, the participants from the  
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Table 3.          
        
Means, Standard Deviations, and Corrected Item-Total Correlations for Each HTAS 
Item 
                
        
  
HTAS 
1999    
HTAS 
2000  
               
        
Scale Items Mean SD r  Mean SD r 
                
        
  1.  HIV testing is not really confidential. 3.40 1.09 0.14  3.89 0.87 0.48 
        
  2.  HIV test information is kept very   3.5 0.98 0.29  4.02 0.87 0.51 
        
       confidential by the medical staff who         
        
       does the testing.        
        
  3.  My family would support me if I  4.28 0.98 0.32  3.99 0.90 0.37 
        
       decided to be tested for HIV.        
        
  4.  I would not want anyone to know if I  2.50 1.12 0.41  3.02 1.20 0.40 
        
       got an HIV test.        
        
  5.  My friends would not look down on   3.87 1.06 0.56  3.69 1.14 0.37 
        
       me if I were tested for HIV.        
        
  6.  Anyone who is tested for HIV is  4.84 0.48 0.21  4.63 0.67 0.39 
        
       Disgusting.         
        
  7.  I would be afraid to get an HIV test     3.65 1.07 0.33  3.74 1.12 0.42 
        
       because people who test positive                  
        
       cannot get health insurance.        
                
Note: HTAS items are on a 5-point Likert-type scale where 1=Strongly Disagree, 5=Strongly Agree   
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Table 3. cont. 
        
        
                
        
  
HTAS 
1999    
HTAS 
2000  
               
        
Scale Items Mean SD r  Mean SD r 
                
        
  8.  People do not assume that everyone  3.39 1.13 0.14  4.47 0.68 0.50 
        
       who is tested for HIV is infected with HIV.       
        
  9.  My parents would be upset if they   3.61 1.29 0.43  3.53 1.26 0.40 
        
       knew I was planning to get tested         
        
       for HIV.        
        
10.  Admitting that you should be tested  3.94 1.09 0.41  3.9 1.06 0.37 
        
       for HIV means that you have         
        
       engaged in immoral behavior.        
        
11.  My friends would support my  4.16 0.85 0.59  4.32 0.73 0.48 
        
       decision to get an HIV test.        
        
12.  I am afraid that if I were to be tested  3.54 0.99 0.46  3.75 1.04 0.47 
        
       for HIV, my name would go into         
        
       public records.         
        
13.  HIV tests give accurate results.  3.46 0.84 0.20  0.78 0.73 0.32 
        
14.  Anyone who is tested for HIV is dirty.  4.74 0.45 0.32  3.22 1.22 0.41 
                
Note: HTAS items are on a 5-point Likert-type scale where 1=Strongly Disagree, 5=Strongly Agree   
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Table 3. cont. 
        
        
                
        
  
HTAS 
1999    
HTAS 
2000  
               
        
Scale Items Mean SD r  Mean SD r 
                
        
15.  It would be embarrassing to get  3.56 1.19 0.62  3.76 1.08 0.54 
        
        tested for HIV.         
        
16.  I would not consider getting an HIV  4.29 0.74 0.44  4.16 0.84 0.48 
        
       test because I would be asked about         
        
       things I have done that could get me         
        
       into trouble        
        
17.  I can talk to my friends about making 4.20 0.76 0.36  3.92 0.93 0.50 
        
       medical decisions.         
        
18.  I would be comfortable talking to an  3.63 1.00 0.36  3.76 0.99 0.32 
        
       HIV counselor about personal         
        
       behaviors that place me at risk for         
        
       HIV infection        
        
19.  People would assume I have HIV if I  3.64 1.06 0.61  3.84 1.00 0.51 
        
       decided to get tested.        
        
        
                
Note: HTAS items are on a 5-point Likert-type scale where 1=Strongly Disagree, 5=Strongly Agree   
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Table 3. cont. 
        
        
                
        
  
HTAS 
1999    
HTAS 
2000  
               
        
Scale Items Mean SD r  Mean SD r 
                
        
20.  I could talk to my friends about  4.00 0.89 0.53  3.97 0.94 0.51 
        
       making the decision to get an HIV test.        
        
21.  My friends would look down on me if  4.12 0.98 0.67  3.92 1.18 0.40 
        
        I were tested for HIV.        
        
22.  My friends would not treat me any  3.88 1.02 0.68  3.68 1.26 0.43 
        
       differently if I were tested for HIV.        
        
23.  I am afraid someone would find out I  3.42 1.15 0.64  3.83 1.05 0.41 
        
        was tested for HIV.         
        
24.  Anyone who is tested for HIV is smart. 4.20 0.88 0.17  4.18 0.91 0.39 
        
25.  I would be embarrassed if my friends  3.87 1.01 0.73  3.37 1.29 0.14 
        
       found out I had decided to have an         
        
       HIV test.        
        
26.  I would not get tested for HIV  4.21 0.66 0.49  4.04 0.72 0.52 
        
       because I would be asked         
        
       information that was too personal.         
                
Note: HTAS items are on a 5-point Likert-type scale where 1=Strongly Disagree, 5=Strongly Agree   
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Table 3. cont. 
        
        
                
        
  
HTAS 
1999    
HTAS 
2000  
               
        
Scale Items Mean SD r  Mean SD r 
                
        
27.  I trust the HIV test counselors and  3.79 0.90 0.33  4.30 0.95 0.28 
        
       nurses to keep my information         
        
       confidential.        
        
28.  I do not have time to get an HIV test.  4.07 0.86 0.31  4.05 0.82 0.34 
        
29.  It would not bother me if someone I  3.02 1.21 0.34  4.12 0.95 0.26 
        
        know sees me going to get an         
        
        HIV test.         
        
30.  My friends would treat me badly if I  4.20 0.86 0.46  4.32 0.90 0.34 
        
        were to be tested for HIV.        
        
31.  I could easily discuss HIV testing  3.25 1.15 0.41  3.23 1.23 0.42 
        
        with my family.        
        
32.  My job would be in danger if my  3.60 0.94 0.23  4.00 1.07 0.44 
        
        boss found out I was tested for HIV.        
        
        
        
        
                
Note: HTAS items are on a 5-point Likert-type scale where 1=Strongly Disagree, 5=Strongly Agree   
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Table 3. cont. 
        
        
                
        
  
HTAS 
1999    
HTAS 
2000  
               
        
Scale Items Mean SD r  Mean SD r 
                
        
33.  My friends would think I am  - - -  4.38 0.78 0.40 
        
        promiscuous if I decided to get         
        
       an HIV test.        
        
34.  People who get HIV tests must  - - -  3.95 0.78 0.51 
        
        be “loose”.        
        
35.  I am afraid my family would think I  - - -  3.73 0.96 0.51 
        
       am gay if I were to get an HIV test.        
        
36.  I know where to go to get an HIV test. - - -  4.00 0.94 0.52 
        
37.  Only IV drug users need to be tested  - - -  3.74 1.16 0.41 
        
        for HIV.        
        
38.  HIV testing takes too long. - - -  3.26 0.97 0.39 
        
        
        
        
        
        
        
        
                
Note: HTAS items are on a 5-point Likert-type scale where 1=Strongly Disagree, 5=Strongly Agree   
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Student Health Center and the introductory psychology student subject pool were 
combined to form one student sample.  
One hundred and ninety-three male (n=50) and female (n=143) students from two 
different campus locations at the University of North Carolina – Wilmington participated 
in Phase 2. There were eight male Testers and 41 female Testers in the student sample. In 
addition, the students ranged in age from 17 to 35 years, with an average age of 19.26 
years (SD = 2.07). The students in this sample were primarily Caucasian (97%) and 
freshmen or sophomores (54% and 23%, respectively).  
 New Hanover County Health Department (HD). Ninety-one clients from the HD 
consented to participate in the current study (males=41 and females=50). Of the 41 
males, 33 were considered Testers, and 40 out of the 50 female participants were Testers. 
The HD clients ranged in age from 18 to 57 with an average age of 26.03 (SD = 7.72). 
Fifty-nine percent (n=53) of the HD participants were Caucasian and 31% (n=28) were 
African American. Ninety-five percent reported at least a high school diploma or GED, 
with more than 60% of the HD clients indicating some amount of college education.  
 Wilmington Health Access for Teens (WHAT). Problems similar to those found 
in the student samples arose in the statistical analysis of the WHAT sample. Because the 
number of participants from WHAT was quite small (n=33), the number of Testers 
obtained from this site was small as well. While 12 participants from WHAT were 
identified as having had an HIV-antibody test, there were no male Testers in this group. 
Therefore, the WHAT data were analyzed separately from the HD and student samples, 
both of which had male and female Testers, and only data from the female participants 
were analyzed for the WHAT sample.  
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Thirty-three male (n=6) and female (n=27) participants from WHAT completed 
the research packets. The age range for WHAT participants was 18 to 23 with a mean age 
of 19.55 years (SD = 1.60). The WHAT sample was largely Caucasian (79%) with 85% 
reporting at least a high school diploma or GED, and approximately 60% indicating some 
level of college education.   
 Procedure 
Data collection was conducted at the health facilities in the same manner as Phase 
1. Clients at each facility who were eligible to participate in the study were approached 
individually. Individuals who chose to participate were given a clipboard and shown to an 
area separate from the common waiting area to complete the questionnaires prior to being 
seen by the clinic counselor or educator. Clipboards with completed research surveys 
were returned to the researcher or facility staff. 
Students from the introductory psychology subject pool received class credit for 
their participation. As in Phase 1, participants from the health facilities were also 
compensated for participation in the research project. The name of each participant who 
completed the research packet at the SHC, HD, or WHAT was entered in a raffle for $50, 
which was held at the end of the study. 
 Materials. In addition to the revised version of the HTAS, participants completed 
location appropriate demographic questions, self-protective information, and scales 
addressing specific components of the health belief model. As the purpose of Phase 2 was 
to assess self-protective behaviors and attitudes regarding HIV-antibody testing, the 
revised HTAS and self-protective efficacy questionnaires were always the first and  
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second surveys in the packet, followed by the demographic information. Remaining 
measures were administered in random order.  
Demographic Information. All participants completed information regarding their 
age, gender, race, and education on a demographic questionnaire (Appendix C). 
Participants also provided information regarding other predictor variables such as age of 
first coitus, whether they were currently sexually active, how often they engaged in self-
protective behaviors (e.g. condom use, refraining from drug or alcohol use before or 
during sex), and whether they had ever had an HIV-antibody test.   
Self-efficacy Scale. A Self-efficacy scale (SES; Appendix E) assessing self-
efficacy regarding performance of the specific self-protective behaviors of discussing 
condom use and HIV-antibody testing with potential sex partners and plans for future 
adherence to safer sex practices was developed during Phase 1. The SES uses a 5-point 
Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree) with responses 
scored so higher scores correspond with a greater level of self-protective self-efficacy. 
Sample statements included “I have discussed safer sex with my past sex partner(s)” and 
“I have discussed HIV testing with my current sex partner(s)”. Cronbach’s alpha for the 
current samples ranged from 0.75 to 0.87. 
AIDS Health Belief Scale. The AIDS Health Belief Scale (AHBS; Zagumny & 
Brady, 1998; Appendix F) has four subscales to assess four components of the HBM: 
perceived susceptibility, severity, benefits of condom use and barriers to condom use. 
Each subscale of the AHBS is a 4-item measurement using a 6-point Likert-type scale 
with higher scores indicating a higher degree of agreement or belief. Perceived severity 
subscale statements include “I would rather have any other terminal illness than AIDS,” 
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and perceived benefits to condom use subscale statements include “I think it is worth the 
effort to have condoms readily available”. Zagumny & Brady report high internal 
consistency for the AHBS with Cronbach’s alpha ranging from 0.82 to 0.93. The 
Cronbach’s alphas for the current study ranged from 0.91 to 0.93. Each subscale of the 
AHBS was used in data analysis. 
Health Locus of Control. The Health Locus of Control (HLOC; Wallston et al., 
1976; Appendix G), an 11-item scale, will be used to assess general perceptions of self-
efficacy related to health-related behaviors and perceptions of personal control over 
health, which speaks directly to the HBM component of cues. The HLOC uses a 6-point 
Likert-type scale scored in the external direction with higher scores indicating an external 
point of view. Sample statements include:  “If I take care of myself, I can avoid illness” 
and “I am directly responsible for my health.”  Wallston et al report the HLOC shows 
adequate internal consistency with Cronbach’s alpha = 0.54. The current samples’ 
Cronbach’s alphas ranged from 0.32 to 0.56. 
Marlow-Crowne Social Desirability. The 33-item Marlow-Crowne Social 
Desirability (SD; Marlow-Crowne, 1972; Appendix H) scale assesses the common issue 
of validity of self-report data. The SD is a true/false scale with 18 items in the true 
direction and 15 items in the false direction with high scores indicating more socially 
desirable answers. Sample items include: I like to gossip at times” and  “When I don’t 
know something, I don’t mind admitting it.”  The MCSD shows good internal 
consistency with Cronbach’s alpha = 0.88; current samples ranged from 0.73 to 0.81.  
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Statistical Analysis 
 Because gender and sample location of participants were possible confounding 
variables, a 2 x 2 x 2 MANOVA was used to determine the independent and interactive 
effects of tester status, gender, or sample location (students vs. health department). The 
following dependent variables were entered in the MANOVA:  HTAS, SES, AHBS, 
HLOC, SD, HIV-testing status, likelihood of obtaining and HIV test within next 12 
months, knowledge of self-protective behaviors, perception of personal susceptibility to 
HIV, condom use within the last 3 months, drug/alcohol use associated with sexual 
activity, comfort level regarding living with an individual with HIV, age of first coitus, 
and current age. Chi-square analysis was used to determine if tester status, gender, and 
sample location were related to ethnicity or history of high risk behaviors that were 
reported using a nominal scale. Stepwise multiple regression analysis was used to 
determine which of the dependent variables best predicted participant’s reported 
likelihood to obtain an HIV test.  
Results 
Students and New Hanover County Health Department 
Table 4 shows a comparison for Testers and Non-testers in the student and HD 
samples by gender for the dependent variables. As can been seen in the table, differences 
are apparent for many of the predictor variables between the student and HD samples, 
between males and females within each sample, as well as between males and females 
across locations (i.e. HTAS scores, HIV-antibody testing status, and condom use).  
MANOVA Analysis. The MANOVA results (Table 5) indicate a significant 3-
way interaction (tester status by location by gender) as well as significant main effects of  
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Table 4.      
     
Means(SD) for Dependent Variables in the MANOVA by Sample, Gender, Test 
Status  
          
     
         Male Students1       Female Students1 
         
     
Variable Tester 
Non-
Tester Tester 
Non-
Tester 
          
     
HIV Testing Attitudes Scale 75.2(13.6) 68.1(8.9) 78.4(10.7) 71.7(11.5)
     
Self-efficacy Scale 77.6(11.1) 68.5(11.3) 79.9(11.8) 70.8(10.4)
     
Health Locus of Control Scale 55.1(9.9) 58.9(11.6) 59.9(11.6) 54.2(9.5) 
     
AIDS Health Belief Scale 65.8(9.5) 63.7(6.9) 67.3(8.7) 65.3(7.9) 
     
Social Desirability Scale 12.8(4.4) 13.7(4.7) 15.6(5.5) 15.0(4.9) 
     
Current Age 20.6(2.0) 19.7(1.6) 19.7(3.1) 18.9(1.7) 
     
Age at first coitus 16.8(1.2) 16.9(1.2) 16.1(1.4) 16.6(1.4) 
     
Number of sex partners within 1.6(1.8) 1.6(1.7) 1.1(0.73) 1.2(0.96) 
the last 3 months     
     
Knowledge of safer sex 8.9(1.1) 7.7(1.7) 8.7(1.5) 8.3(1.7) 
techniques3     
          
     
1 - Student data combined from campus locations (subject pool and health center)  
     
2 – Clients from New Hanover County Health Department 
 
3 - Variable is on a scale of 1-10, with 10 indicating greater knowledge  
     
4 - Variable is on a scale of 1-10, with 10 indicating more consistent condom use  
     
5 - Variable is on a scale of 1-10, with 10 indicating greater susceptibility  
     
6 - Variable is on a scale of 1-10, with 10 indicating greater likelihood  
     
7 - Variable is on a scale of 1-10, with 10 indicating greater substance use  
     
8 - Variable is on a scale of 1-10, with 10 indicating greater comfort level  
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Table 4. cont. 
     
     
          
     
         Male Students1       Female Students1
         
     
Variable Tester Non-Tester Tester Non-Tester 
          
     
     
Condom use within the last 3 5.4(3.7) 6.4(3.1) 6.2(3.7) 6.2(3.7) 
months4     
     
Perception of personal  2.5(2.9) 2.8(1.7) 2.7(1.5) 2.4(1.5) 
susceptibility5     
     
Likely to have HIV test within 4.1(4.0) 2.4(2.7) 5.0(3.7) 1.5(2.5) 
the next year6     
     
Drug/alcohol use with 7.5(2.9) 3.7(2.9) 2.9(2.3) 2.7(2.1) 
associated with sex7     
     
Know a person living with  6.3(3.3) 5.7(2.6) 6.5(2.7) 5.7(2.4) 
HIV or AIDS     
     
     
     
     
          
     
1 -Student data combined from campus locations (subject pool and health center)  
     
2 - Clients from New Hanover County Health Department   
     
3 - Variable is on a scale of 1-10, with 10 indicating greater knowledge  
     
4 - Variable is on a scale of 1-10, with 10 indicating more consistent condom use  
     
5 - Variable is on a scale of 1-10, with 10 indicating greater susceptibility  
     
6 - Variable is on a scale of 1-10, with 10 indicating greater likelihood  
     
7 - Variable is on a scale of 1-10, with 10 indicating greater substance use  
     
8 - Variable is on a scale of 1-10, with 10 indicating greater comfort level  
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Table 4. cont. 
     
     
          
     
 Male HD2 Female HD2 
         
     
Variable Tester 
Non-
Tester Tester 
Non-
Tester 
          
     
HIV Testing Attitudes Scale 71.5(12.7) 68.5(11.7) 76.5(13.3) 76.3(12.0) 
     
Self-efficacy Scale 73.1(14.3) 67.8(7.3) 82.9(12.8) 73.5(20.1) 
     
Health Locus of Control Scale 54.9(7.2) 56.3(10.6) 55.9(10.5) 54.8(6.8) 
     
AIDS Health Belief Scale 68.5(8.9) 67.6(12.4) 68.9(11.2) 71.0(10.2) 
     
Social Desirability Scale 18.2(6.1) 15.4(7.1) 17.6(5.6)) 18.5(4.1) 
     
Current Age 25.9(6.6) 22.1(3.6) 26.9(9.2) 26.0(7.2) 
     
Age at first coitus 15.2(2.8) 15.5(0.92) 16.3(2.1) 15.3(1.6) 
     
Number of sex partners within 2.1(2.63) 1.1(0.64) 1.6(1.4) 1.3(0.94) 
the last 3 months     
     
Knowledge of safer sex 7.8(2.1) 7.1(2.7) 8.7(1.8) 7.2(3.0) 
techniques3     
          
     
1 - Student data combined from campus locations (subject pool and health center)  
     
2 - Clients from New Hanover County Health Department   
     
3 - Variable is on a scale of 1-10, with 10 indicating greater knowledge  
     
4 - Variable is on a scale of 1-10, with 10 indicating more consistent condom use  
     
5 - Variable is on a scale of 1-10, with 10 indicating greater susceptibility  
     
6 - Variable is on a scale of 1-10, with 10 indicating greater likelihood  
     
7 - Variable is on a scale of 1-10, with 10 indicating greater substance use  
     
8 - Variable is on a scale of 1-10, with 10 indicating greater comfort level  
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Table 4. cont. 
     
     
          
     
 Male HD2 Female HD2 
         
     
Variable Tester Non-Tester Tester Non-Tester 
          
     
Condom use within the last 3 5.0(3.1) 6.7(2.6) 4.9(2.8) 4.5(2.7) 
months4     
     
Perception of personal  3.8(1.9) 4.0(2.2) 3.8(2.3) 5.4(2.9) 
susceptibility5     
     
Likely to have HIV test within 6.2(3.8) 4.8(3.0) 6.4(3.6) 4.6(3.0) 
the next year6     
     
Drug/alcohol use with 3.5(2.7) 5.1(2.3) 3.8(3.0) 3.5(2.5) 
associated with sex7     
     
Know a person living with  4.5(2.3) 5.0(3.0) 5.1(2.9) 4.0(2.6) 
HIV or AIDS     
     
     
     
     
     
          
     
1 - Student data combined from campus locations (subject pool and health center)  
     
2 - Clients from New Hanover County Health Department   
     
3 - Variable is on a scale of 1-10, with 10 indicating greater knowledge  
     
4 - Variable is on a scale of 1-10, with 10 indicating more consistent condom use  
     
5 - Variable is on a scale of 1-10, with 10 indicating greater susceptibility  
     
6 - Variable is on a scale of 1-10, with 10 indicating greater likelihood  
     
7 - Variable is on a scale of 1-10, with 10 indicating greater substance use  
     
8 - Variable is on a scale of 1-10, with 10 indicating greater comfort level  
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Table 5.        
     
2 x 2 x 21 MANOVA for Student and Health Department Participants  
          
     
Effect Λ F df p 
          
     
HIV Testing Status 0.85 2.64 
(16, 
246) 0.0007 
     
Location 0.72 6.13 
(16, 
246) 0.0001 
     
Gender 0.89 1.92 
(16, 
246) 0.019 
     
HIV Testing Status x Location 0.91 1.53 
(16, 
246) 0.088 
     
HIV Testing Status x Gender 0.94 1.07 
(16, 
246) 0.385 
     
Location x Gender 0.93 1.14 
(16, 
246) 0.321 
     
HIV Testing Status x Location x Gender 0.90 1.71 
(16, 
246) 0.045 
          
     
1 - HIV Testing Status (tester/non-tester) x Location (campus/health department) x Gender  
 
(male/female) 
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HIV test status, location, and gender. Post-hoc univariate analysis indicated the 3-way 
interaction was significant for only two dependent variables: the use of drugs or alcohol 
associated with sexual activity and social desirability [F (1, 261) = 8.40, p < 0.004 and F 
(1, 261) = 4.19, p < 0.04, respectively]. To further analyze the triple interaction for these 
variables, the data were sorted by location and 2-way post-hoc general linear model 
(GLM) analysis of the data was conducted.  
On further analysis, the social desirability scale yielded no significant effects for 
the health department sample. In the student sample, there was only a main effect for 
gender [F (3, 189) = 4.42, p < 0.04] with females giving more socially desirable answers 
than males (females = 15.2 and males = 13.4). 
The post-hoc GLM analysis for drug/alcohol use associated with sexual activity 
also yielded no significant differences for the health department sample. However, in the 
student sample, a significant interaction between HIV testing status and gender [F (3, 
189) = 12.34, p < 0.0006] was found. Post-hoc analysis of this interaction determined 
there were no significant differences between female Testers and Non-testers in the 
student sample regarding drug/alcohol use with sexual activity (p > 0.05). However male 
Testers reported a greater number of instances of sexual activity associated with 
drug/alcohol than Non-testers (p > 0.05). 
The post-hoc univariate analysis confirmed only significant main effects for the 
other dependent variables (Table 6). Testers scored significantly higher than Non-testers 
on HTAS (Tester M=75.57, Non-tester M=70.60), SES (Tester M=79.13, Non-tester M 
=70.11), and rating of knowledge regarding self-protective behaviors (Tester M=8.48, 
Non-tester M=7.98). Testers were significantly older than Non-testers (Tester M=23.84 
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Table 6.      
    
Significant Main Effects from Univariate Analyses    
        
    
Variable F df p 
        
    
HIV Testing Status    
    
          HTAS 7.07 (7, 261) 0.008 
    
          SES 17.25 (7, 261) 0.0001 
    
          Current age 5.03 (7, 261) 0.03 
    
          Knowledge of self protective behaviors 12.08 (7, 261) 0.0006 
    
Gender    
    
          HTAS 4.93 (7, 261) 0.03 
    
          SES 5.03 (7, 261) 0.03 
    
Location    
    
          Susceptibility subscale of AHBS 6.91 (7, 261) 0.009 
    
          Comfort living with person with HIV/AIDS 10.21 (7, 261) 0.002 
    
          Current age 37.74 (7, 261) 0.0001 
    
          Age of first coitus 12.96 (7, 261) 0.0004 
    
          Knowledge of self protective behaviors 6.64 (7, 261) 0.01 
    
          Perception of personal susceptibility 23.06 (7, 261) 0.0001 
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and Non-tester M=19.56). Gender effects were only significant for two variables with 
females scoring higher than males for both: HTAS (males M=69.88, females M=74.07) 
and SES (males M=70.99 and females M=75.39). The main effects of location were 
significant for the susceptibility subscale of the AHBS (HD M=59.63, students M=49.56), 
knowledge regarding self-protective behaviors degree (HD M=8.27, students M=8.05), of 
comfort living with an individual who has HIV (HD M=4.69, students M=5.90), current 
age (HD M=25.91, students M=19.32), age of first coitus (HD M=15.67, students 
M=16.56), and perceptions of personal susceptibility (HD M=3.88, students M=2.55), 
with the health department clients consistently scoring higher than the student sample 
except for comfort living with an individual infected with HIV. 
Stepwise Multiple Regression. Stepwise multiple regression was conducted on the 
student and HD samples separately using the self-reported likelihood of obtaining an 
HIV-antibody test within the next 12 months as the criterion variable. For the student 
sample, 8% of the variance could be accounted for by HTAS scores [F (1, 83) = 7.18, p < 
0.009]. No other variables were related to the likelihood of getting an HIV test. In the HD 
sample, HTAS scores, SES scores, perception of personal susceptibility to HIV, and 
drug/alcohol use associated with sexual activity were significant predictors and accounted 
for 28% of the variance [F (4, 179) = 17.51, p < 0.0001; see Table 7]. 
Chi-square. Chi-square analysis of the descriptive variables yielded two 
significant differences between testers and non-testers when sorted by location:  number 
of times treated for a sexually transmitted disease (HD: χ2 (1) = 7.78, p < 0.005; students: 
χ2 (1) = 12.06, p < 0.001) and number of unplanned pregnancies (HD: not significant;  
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Table 7.      
    
Significant Predictor Variables for Likelihood of Obtaining an HIV Test 
        
    
Variable B F p 
        
    
HIV Testing Attitude Scale 0.0573 7.78 0.006 
    
Self-efficacy Scale 0.0786 15.47 0.0001 
    
Drug/alcohol use associated with sex 0.2233 7.55 0.007 
    
Perception of personal susceptibility 0.5517 18.37 0.0001 
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Table 8.      
    
Means(SD) for WHAT1 Sample for Predictor Variables  
        
    
Variable Tester Non-testers 
        
    
Current Age  21.0(1.7) 19.0(1.3) 
    
Age at first coitus  16.0(2.4) 17.0(2.2) 
    
Number of sex partners within last 3 months 1.3(1.2) 1.3(0.5) 
    
Knowledge of safer sex methods2 9.1(1.2) 7.3(2.6) 
    
Condom use within the last 3 months3 6.3(2.9) 6.5(3.3) 
    
Perception of personal susceptibility4 3.4(1.7) 4.3(3.2) 
    
How likely to get HIV test within year5 6.2(3.6) 3.2(2.1) 
    
Drug/alcohol use associated with sex6 3.3(2.3) 3.3(1.8) 
    
Comfort living with person with HIV or AIDS7 4.5(2.4) 3.7(2.1) 
        
1 - Wilmington Health Access for Teens   
    
2 - Variable is on a scale of 1-10, with 10 indicating greater knowledge  
    
3 - Variable is on a scale of 1-10, with 10 indicating more consistent condom use 
    
4 - Variable is on a scale of 1-10, with 10 indicating greater susceptibility  
    
5 - Variable is on a scale of 1-10, with 10 indicating greater likelihood  
    
6 - Variable is on a scale of 1-10, with 10 indicating greater substance use  
    
7 - Variable is on a scale of 1-10, with 10 indicating greater comfort level  
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students: χ2 (1) = 6.23, p < 0.04). For both dependent variables, Testers scored higher 
than Non-testers. 
Wilmington Health Access for Teens 
Table 8 shows a comparison of sample characteristics for Testers and Non-testers 
in the WHAT sample. As can been seen from the table, differences are apparent for many 
of the predictor variables (i.e. knowledge of self-protective methods, age at first coitus, 
and). To determine if the differences between Testers and Non-testers evident in the table 
were significant, a MANOVA was run. 
Main Effects. The overall MANOVA run on the data for the WHAT sample was 
not significant [F (1, 24) = 0.69, p < 0.76], indicating that Testers and Non-testers in this 
sample of females did not differ. 
Stepwise Multiple Regression. Stepwise multiple regression was also conducted 
on the WHAT sample data using the likelihood of obtaining an HIV-antibody test as the 
criterion variable. Only one variable (alcohol use associated with sexual activity) was a 
significant predictor (p < 0.02), accounting for 19% of the variance [F (1, 24) = 5.78, p < 
0.02]. 
Chi-square. Chi-square analysis of the data from the WHAT sample found no 
significant differences between Testers and Non-testers for the nominal predictor 
variables (e. g. race, number unintended pregnancies, treatments for STD’s, individuals 
who know someone infected with HIV). 
Discussion 
The Health Belief Model has been utilized to examine a variety of preventive 
health behaviors ranging from smoking cessation to dental flossing to exercise. Further, 
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the core components of the model (i.e. perceived personal susceptibility to the disease, 
perceived severity of the disease, benefits of engaging in a preventive behaviors, and 
costs associated with those behaviors), as well as expanded components (i.e. cues to 
engage in the prescribed behavior and self-efficacy to perform that behavior) have been 
used to examine specific behaviors associated with the prevention of sexually transmitted 
diseases, including HIV. While the majority of this research has focused on condom use 
as a preventive behavior for HIV prevention (Basen-Enquist, 1994; Mahoney et al., 1995; 
Winfield & Whaley, 2002; Wulfert & Wan, 1993), limited information is available 
regarding the specific health protective behavior of obtaining an HIV-antibody test within 
the components of the model (Maguen, Armistead, & Kalichman, 2000; Flowers, 
Duncan, & Knussen, 2003).  
Phase 1 of the current study assessed the generalized use of the HIV testing 
attitude scale (HTAS; Boshamer & Bruce, 1999). The appropriateness of this scale to 
investigate HIV testing attitudes in other populations in addition to college populations is 
evidenced by strong correlations for similar items from the original 82 questions 
developed by experts in the field for Boshamer & Bruce (1999). One noted difference 
was that current HD participants did not have the same logistical concerns as the 
Boshamer & Bruce (1999) or current student sample. This may be explained by the fact 
that HD participants were in a facility where counselors educated and encouraged HIV-
antibody testing during most client contacts. Although the University of North Carolina – 
Wilmington student health center started providing HIV-antibody testing during the fall 
semester of 2000, at the time of this study, this was still a new service of which very few 
students were aware.  
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As previously stated, much research regarding HIV prevention has investigated 
the self-protective behavior of condom use, in Phase 2 of the current study, the 
components of the HBM were used to assess the specific self-protective behavior of 
obtaining an HIV-antibody test. As with previous research, the hypotheses set forth in 
this study found mixed support for the HBM across the three samples. 
As hypothesized, there were no significant differences between Testers and Non-
testers regarding perceptions of HIV infection and AIDS as severe health concerns and 
similar levels of knowledge regarding the disease were reported across all research 
locations.  This finding may be because information regarding HIV infection and AIDS is 
readily available in the media. Thus, Testers and Non-testers appear to have similar 
awareness and health beliefs regarding HIV. However, it is important to remember that 
previous research indicates that knowledge alone is not an adequate motivator to change 
behavior regarding health practices (Baldwin & Whitley, 1990; DiClemente, 1994; 
Jemmott, Jemmott & Fong, 1992). 
There were mixed results regarding the hypotheses that there would be a 
quantifiable difference between Testers and Non-testers in perceptions of benefits and 
barriers to obtaining an HIV-antibody test. There were significant differences in HTAS 
scores in the student and HD samples with Testers consistently scoring higher, which 
supported the hypothesis that Testers have a more positive attitude toward and see more 
benefit from obtaining an HIV-antibody test than Non-testers. However, this hypothesis 
was not supported in the WHAT sample, as there were no significant differences in 
HTAS scores between the Testers and Non-testers for this group.  
 
 
 
52
Significant differences between Testers and Non-testers were also hypothesized 
for perceptions of personal susceptibility and self-efficacy for performing other self-
protective behaviors. While there were no significant differences between Testers and 
Non-testers regarding perceptions of personal susceptibility to HIV infection, there were 
differences for self-efficacy, with Testers scoring significantly higher than Non-testers in 
their confidence to perform other self-protective behaviors (e.g. talking with potential sex 
partners regarding condom use and HIV-antibody testing).  
The lack of significant differences between Testers and Non-testers regarding 
personal susceptibility may be viewed two ways. First, it may be that Testers are the 
“worried well” who do not truly see themselves as at risk for HIV, but are motivated to 
be tested for some other reason, whether it be at a partner’s request or for personal sense 
of relief. In fact, Flowers et al. (2003) found that “peace of mind” was a common reason 
given for choosing to have an HIV-antibody test for those individuals who expected that 
their test results would be negative. Conversely, for those individuals in the same study 
who expected to have a positive test result, not knowing their HIV status was reportedly 
preferable to knowing that they were HIV positive. Thus, it may be that Non-testers see 
themselves as just as susceptible to HIV as those who choose to obtain an HIV-antibody 
test, but do not obtain the test out of anxiety about the results or fear of their ability to 
cope with the test results. This is further supported in the findings associated with Conley 
et al. (1999) MACS study and the theory posited by Wilson et al. (1999) regarding the 
lack of women returning for HIV-antibody tests who had stated they would return.  
Testers were hypothesized to see themselves as having more control over whether 
or not they contract HIV infection than Non-testers as evidenced by a lower score on the 
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Health Locus of Control Scale and reporting routine practice of other self-protective 
behaviors. However, there were no significant differences between Testers and Non-
testers on the HLOC. The HLOC mean scores for each location ranged from 53.3 to 59.9 
for Testers, while Non-testers mean scores ranged from 50.8 to 58.5. Recall that the 
HLOC is a 100-point scale with higher scores indicating a view more external control 
view regarding health issues. Thus, in the current study Testers and Non-testers appeared 
to hold similar views regarding their level of control over contracting the HIV infection. 
Such similar mid-range scores with limited variability could be due to a number of 
reasons: the scale is either not appropriate with the current samples, may be outdated, or 
was not given due attention by the participants. 
Recent studies suggest that the construct of health locus of control has very 
limited predictive value in populations of women who have been victims of abuse 
(Simoni & Ng, 2002) or perceive themselves as having less power than their dating 
partners (Rosenthal, et al., 2002). Statistics suggest that approximately 1 in every 3 
women world wide has been physically beaten, the victim of non-consentual sex, or 
abused in some other manner during her lifetime (Heise, Ellsberg, & Gottemoeller, 
1999). Furthermore, in the United States, 1 in 5 high school girls report having been the 
victim of sexual and/or physical abuse by a romantic partner (Silverman, Raj, Mucci, & 
Hathaway, 2001). Thus, perceptions of personal power and control in a relationship may 
be greatly impact preventive behaviors directly related to sexual activity. The participants 
in the current study were primarily female (69%), which may influence perceptions of 
locus of control and efficacy.    
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Significant differences were found between Testers and Non-testers for age at the 
time of assessment, HTAS, SES, knowledge of self-protective behaviors, and alcohol use 
associated with sexual behaviors. Testers were older, had more favorable attitudes toward 
testing, reported greater self-efficacy, reported higher levels of knowledge regarding self-
protective behaviors, and were more likely to have used alcohol when engaging in sexual 
activity. Intuitively, one would expect an individual who has had an HIV-antibody test to 
have a more favorable attitude toward the test than an individual who did not engage in 
that same behavior. Alcohol is considered a disinhibitor for most individuals, as such, 
alcohol use has been correlated with an increase in risky sexual behavior. Thus, if an 
individual perceived their behavior as putting him or herself at risk for HIV, the decision 
to obtain an HIV-antibody test may be based upon risky sexual behavior associated with 
alcohol use. 
In addition, significant gender differences were also found for HTAS and SES, 
with female participants having more favorable attitudes toward HIV testing as well as 
greater degrees of reported self-efficacy. Furthermore, significant differences were found 
between location samples with participants from the New Hanover County Health 
Department STD clinic being older at the time of assessment and younger at the age of 
first coitus, indicating greater personal susceptibility, expressing more comfort level 
living with a person infected with HIV or AIDS. Student participants indicated a greater 
amount of knowledge regarding prevention.  
Neither the MANOVA and Chi-square analyses for the WHAT sample were 
significant. In fact, the only significant finding in the WHAT sample was found via the 
stepwise regression. Alcohol and drug use associated with sexual activity was a 
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significant predictor of whether or not a participant reported an intention to have an HIV-
antibody test within the next year with Testers reporting a higher degree of intent. The 
lack of significant findings in this sample may be due to the small overall sample size 
(n=27), small number of Testers (n=12), lack of variability within the sample, or some 
unknown variable.   
Limitations of the Current Research 
 One major limitation of the current study was the overall lack of participants at 
certain locations, and more specifically the general lack of male Testers. There were very 
few male Testers outside of the health department (HD) location, resulting in all data 
from students from the University of North Carolina – Wilmington (UNCW) campus 
being combined for analysis, and only using data from females at the Wilmington Health 
Access for Teens (WHAT). This low number of male participants in the current study 
limits the generalizability of the findings.  
Other limitations of the current study include the selection process of participants 
and self-report nature of the data. To minimize the self-selection process by participants 
as they signed-up, suggestions found in Weinhardt et al. (1991) were followed, and the 
current study was posted as being about “Attitudes and Behavior” with no mention of 
sexuality or HIV on the sign-up sheet. In a further attempt to minimize these problems, 
anonymity of responses to survey questions was stressed so that participants felt 
comfortable answering honestly. Finally, care was taken to avoid misinterpretation of 
specific items. Questions regarding behavior (e.g. sexual activity, condom use) were very 
specific with timeline indicators or definitions where appropriate (i.e. On this 
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questionnaire, sex is defined as any act of oral, vaginal, or anal intercourse. or Have you 
had sex in the last 3 months?). 
In addition, the participants from the UNCW campus were recruited from two 
distinct groups:  the introductory psychology subject pool and the student health center 
(SHC). It seems the saliency of health concerns for these two groups would be quite 
different. At the very least, the environment in which they completed their questionnaire 
was functionally different. Students at the SHC were in a medical facility with 
educational material available and in plain view, including information about STD and 
HIV-antibody testing and were approached individually by a researcher regarding 
participation. Subject pool participants signed up for the study on a sign-up sheet to 
receive class credit and completed the questionnaires in a classroom with no health 
information visible.   
The overall number of participants from the WHAT facility was small, due in part 
to the age requirements of the study; participants had to be 18 years or older. In addition, 
there were only a very small number of male participants with no male Testers identified.  
Having an exclusively female sample from the WHAT location meant this sample could 
not be analyzed with the student and HD samples, both of which had male Testers. 
The Cronbach’s alphas obtained in the current study for the Health Locus of 
Control (HLOC) scale were surprisingly low, ranging from .32 to .56. These low figures 
may be the result of participant error. Participants may not have understood the questions 
or may have lost interest or been fatigued when completing the HLOC due to the number 
of other questionnaires. However, other than the HIV testing and self-efficacy scales, the 
order of the remaining questionnaires was randomized to reduce such order effects. The 
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HLOC was developed by Wallston et al. in 1976. Consequently, validation of the items in 
the HLOC with factor analysis is warranted. 
Implications for Future Research  
The overall lack of male Testers in the current study might suggest that males are 
less likely to obtain an HIV-antibody test, or that males are less likely to participate in 
survey research with a raffle drawing, or simply that males are less likely to attend the 
facilities where the data was gathered. The driving force behind the minimal 
representation of male Testers cannot be discerned from the current study. Consequently, 
this study should be replicated with care taken to increase the number of male 
participants. This may be accomplished by collecting data for a longer period of time, 
from different facilities, and/or with a different incentive to complete the research packet.  
Although item-total correlations for the original set of 82 questions for the HTAS 
were quite similar between the Boshamer & Bruce (1999) 1995 sample and the current 
samples, there were differences in significant items. This may indicate a general change 
in attitudes regarding HIV-antibody testing or may be due to differences in concerns and 
attitudes between a college student population and a health department population.  
Therefore, further assessment of the HTAS is warranted, and items on the HTAS should 
be validated with factor analysis for a college population and generalized use. 
Finally, at the time the current study was conducted, an HIV-antibody test was 
almost exclusively done via drawing blood. However, with recent technological 
advances, saliva may also be reliably tested for HIV antibodies. As some individuals 
have fears associated with needles and having their blood drawn, they may avoid having 
an HIV-antibody test because of the collection process. Recent research indicates that, 
 
 
58
when given an option, individuals in a substance abuse treatment facility (Pugatch et al., 
2001) and adolescents being held in detention and juvenile justice facilities (Bauserman, 
Ward, Eldred, & Swetz, 2001) would prefer to have an oral as opposed to blood HIV-
antibody test. Thus, more comprehensive research regarding HIV-antibody testing should 
consider using this new form of testing procedure. 
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APPENDIX 
 
Appendix A.  Preliminary 82-item HTAS questionnaire 
 
HTAS 
Please use the following scale to respond to the statements: 
  
SA:   Strongly Agree 
  A:   Agree 
  N:   Neither agree nor disagree 
  D:   Disagree 
SD:   Strongly Disagree 
 
_______  1.  My friends would look down on me if I were tested for HIV.  
_______  2.  I do not need to be tested for HIV because I do not think I have the  
                     infection. 
_______  3.  HIV tests are too expensive.  
_______  4.  I would be tested for HIV if I knew where to go for a test. 
_______  5.  HIV tests should always be free. 
_______  6.  I am afraid someone would find out I was tested for HIV. 
_______  7.  My friends would treat me badly if I were to be tested for HIV. 
_______  8.  My job would be in danger if my boss found out I was tested for  
                     HIV. 
_______  9.  My friends would support my decision to get an HIV test. 
_______  10.  My friends would think I am promiscuous if I decided to get an HIV  
                       test. 
_______  11.  I would not want anyone to know if I got an HIV test. 
_______  12.  There is no need to get an HIV test because what you don’t know  
                       won’t hurt you. 
_______  13.  I would be afraid to get an HIV test because people who test  
                       positive cannot get health insurance. 
_______  14.  Anyone who is tested for HIV must be concerned about his or her  
                       health. 
_______  15.  It would be scary to get an HIV test. 
_______  16.  Only gay people need to be tested for HIV. 
_______  17.  I would be scared to know the results of an HIV test. 
_______  18.  I would not want to know if I were HIV positive.  
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SA:  Strongly Agree 
  A:   Agree 
  N:   Neither agree nor disagree 
  D:   Disagree 
SD:   Strongly Disagree 
 
_______  19.  I am afraid my friends would think I am gay if I get tested for HIV. 
_______  20.  People who get HIV tests must be “loose”. 
_______  21. Because so many people in my community have HIV/AIDS, I  
                      should get an HIV test. 
_______  22. My friends would not treat me any differently if I were tested for  
                      HIV. 
_______  23.  I could talk to my friends about making the decision to get an HIV  
             test. 
_______  24.  Admitting that you should be tested for HIV means that you have  
                       engaged in immoral behavior. 
_______  25.  It is important to know your HIV status, so that if your are positive  
                       you will not infect others. 
_______  26.  I don’t know where HIV tests are given. 
_______  27.  There is no reason to get tested for HIV, because all it can tell is  
                        whether you are dying or not. 
_______  28.  Anyone who is tested for HIV is disgusting. 
_______  29.  Anyone who is tested for HIV is smart.                                
_______  30.  People would assume I have HIV if I decided to get tested. 
_______  31.  I do not care if I have HIV or not. 
_______  32.  I do not know what behaviors place me at risk for HIV. 
_______  33.  I trust the HIV test counselors and nurses to keep my information  
                       confidential. 
_______  34.  I would not get tested for HIV because I would be asked  
                       information that was too personal. 
_______  35.  I am afraid my family would think I am gay if I were to get an HIV  
                       test. 
_______  36.  I think that people who test positive for HIV lose their jobs. 
_______  37.  Anyone who is tested for HIV must be concerned about their  
                sexual partner’s health. 
_______  38.  I do not have time to get an HIV test. 
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SA:  Strongly Agree 
  A:   Agree 
  N:   Neither agree nor disagree 
  D:   Disagree 
SD:   Strongly Disagree 
 
_______  39.  Waiting to get the result of an HIV test would be too scary. 
_______  40.  I am afraid that if I were to get tested for HIV my name would go  
                       into public records. 
_______  41.  I would be more likely to get tested for HIV if my friends also  
                      decided to get tested. 
_______  42.  Knowing the result of you HIV test would be better than not  
                       knowing. 
_______  43.  I would not consider getting an HIV test because I would be asked  
                       about things I have done that could get me into trouble. 
_______  44.  I think doctors do not like to treat people who test positive for HIV. 
_______  45.  HIV test are not accurate. 
_______  46.  Anyone about to enter a new relationship should be tested for HIV. 
_______  47.  Knowing whether or not I have HIV would be the last thing I would  
                       want to know.  
_______  48.  HIV test information is kept very confidential by the medical staff  
                       who does the testing. 
_______  49.  It would be embarrassing to get tested for HIV.  
_______  50.  My parents would be upset if they knew I was planning to get  
                       tested for HIV. 
_______  51.  My family would support me if I decided to be tested for HIV. 
_______  52.  I would not want to be asked about illegal behavior if I were to be  
                       tested for HIV. 
_______  53.  I would be embarrassed to talk to an HIV counselor about personal  
                       behaviors that place me at risk for HIV infection. 
_______  54.  I am concerned about the confidentiality of HIV tests. 
_______  55.  Not knowing your HIV test result would be more stressful than  
                       knowing it. 
_______  56.  I do not know what happens when you get an HIV test. 
_______  57.  People assume that everyone who is tested for HIV is infected.  
_______  58.   Anyone who is tested for HIV is dirty. 
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SA:  Strongly Agree 
  A:   Agree 
  N:   Neither agree nor disagree 
  D:   Disagree 
SD:   Strongly Disagree 
 
_______  59.  I could easily discuss HIV with my family.  
_______  60.  It would not bother me if someone I know sees me going to get an  
                       HIV test. 
_______  61.  Anyone planning to have children should be tested for HIV. 
_______  62.  It would be embarrassed if my friends found out I had decided to  
                       get an HIV test. 
_______  63.  I am afraid of medical procedures that involve needles. 
_______  64.  You have to reveal too much private information if you decide to  
                       get an HIV test. 
_______  65.  My friends would not look down on me if I were to be tested for  
                       HIV. 
_______  66.  HIV or AIDS only affects people in other parts of the country. 
_______  67.  I could never talk to my friends about making the decision to get  
                       an HIV test. 
_______  68.  Even if I knew my HIV test result, I would not change my behavior. 
_______  69.  HIV tests give accurate results. 
_______  70.  Having to wait for an HIV test result would be agonizing.  
_______  71.  HIV testing is not really confidential. 
_______  72.  People should get an HIV test about once a year. 
_______  73.  It would be easier for someone to deny they are at risk for HIV  
                       than to admit they need to be tested. 
_______  74.  I know where to go to get an HIV test. 
_______  75.  Only IV drug users need to be tested for HIV. 
_______  76.  I am concerned about my health. 
_______  77.  HIV/AIDS is a problem in my community. 
_______  78.  I can talk to my friends about medical decisions. 
_______  79.  HIV testing locations are convenient. 
_______  80.  HIV testing takes too long. 
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SA:  Strongly Agree 
  A:   Agree 
  N:   Neither agree nor disagree 
  D:   Disagree 
SD:   Strongly Disagree 
 
_______  81.  I would have trouble getting transportation to an HIV testing site. 
_______  82.  Only people under 30 really need to be tested for HIV. 
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Appendix B.  Letter of support from health facility for research participation. 
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Appendix C. Demographics survey given to student participants. 
 
On this survey, the term “sex” means ANY act of vaginal, anal, or oral sex. 
             
1.   How old are you? ___________           
 
2. How would you describe yourself (please circle one): 
 
White        African -American       Hispanic       Asian Native-American  Other 
 
3.  Are you:   ______ Male      _____ Female 
 
4. Year in school:  ____ Freshman    ____ Sophomore     ____ Junior     ____ Senior 
 
 
5. Please check which describes you:  ______ I have had sex in the last 3 months.  
          ______ I have not had sex in the last 3 months. 
   ______ I have never had sex. 
 
6. When you have sex, it is with: ______ Men only 
______ Women only 
______ Either men or women 
______ I have never had sex 
 
7.   How old were you the first time you had sex?  ________ 
 
8. How many sex partners have you had in the last 3 months?  ________ 
 
9. How many sex partners have you had in your lifetime?  ________ 
 
10. Use the scale below to show how often you have used alcohol or drugs before or 
during sex in the last 3 months. 
      1           2            3            4             5            6            7            8            9            10 
    Never                     Sometimes                                        Every time 
 
11. Using the scale below, show how you would feel about going to class with someone 
who is HIV positive?  
       1            2            3            4            5            6            7            8            9            10 
Very Uncomfortable                     Very 
comfortable 
 
12. On the scale below, indicate how you would feel about sharing a dorm, house or   
      apartment with someone who is HIV positive? 
      1            2            3            4            5            6            7            8            9            10 
Very Uncomfortable                                                Very 
comfortable 
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13. Use the scale provided to rate your knowledge of HIV and AIDS. 
      1            2           3             4            5             6            7            8            9            10 
  Nothing                                  A lot  
 
14. On the scale, rate your knowledge of ways you can protect yourself from getting HIV. 
      1            2           3             4            5             6            7            8            9            10 
I don’t know how                      I know some ways                                                
I know very many  
to protect myself          to protect myself         ways to 
protect myself     
15.  What do you think is the chance that you will ever catch HIV or AIDS?  
       0         1          2          3           4            5            6           7             8           9         10 
 Not at all                                                                                                                                           Definitely 
 
16. Using the scale below, how often do you or your partner use condoms? 
      1            2            3            4            5             6            7            8            9            10                              
   Never                                                                                                               
Every time 
 
17. Using this scale, show how often you share needles with someone else. 
0             1         2          3          4          5          6          7          8          9          10 
I never use       I never                                     I sometimes                   I 
share every  
   needles           share      share                 time 
 
 
18.  Are you getting an HIV test today?  _____ Yes          _____ No 
 
    18a. Other than today, have you ever had an HIV test?   _____ Yes    ____ No                          
     
    18b.  What prompted you to get your HIV test? 
 
  
 
     18c.  Did you get your HIV test results? _____ Yes    ____ No                           
 
     18d.  If you did not get your test results, please say why. 
 
 
     
19.  How likely are you to get an HIV test in the next year? 
       0           1           2           3          4          5           6           7           8          9         10 
 Not at all                                           Definitely  
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20.  Have you ever had or caused an unplanned pregnancy? _______ Never 
          _______ 1-2 times 
                     _______ More than twice 
 
 
 
 
 
21. Have you ever been treated for: 
 
Gonorrhea (gc, drip, clap)                  ______ Yes    ______ No 
      Genital Warts (hpv)                           ______ Yes    ______ No  
      Herpes                                                ______ Yes    ______ No 
      PID (pelvic inflammatory disease)    ______ Yes    ______ No 
      Trichomonas (trick)                         ______ Yes     ______ No 
      Syphilis (bad blood)       ______ Yes     ______ No 
      Chlamydia                                          ______ Yes     ______ No   
 
 
22.  I personally know someone who:            
 is Gay               ____Yes      ____No 
  is a Lesbian     ____Yes       ____No 
  is Bisexual       ____Yes       ____No 
  is HIV positive or has AIDS     ____Yes        ____No 
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Appendix D.  Questions piloted in Phase 1 for Phase 2. 
 
PQSS 
1.  Age ___________           
 
2.  Race:     White       African American      Hispanic      Other 
 
3.  Gender:  ______ Male      _____ Female 
 
4.  Year in School:   ____Freshman   _____Sophomore    _____Junior     _____Senior 
 
5.  I am:    ______ A virgin   
______ Not currently sexually active  (NO sex in last 3 months) 
______ Currently sexually active (sex within the last 3 months) 
                  
 
7. When I have sex, it is with 
       0                    1         2         3         4         5         6         7         8         9         10  
Never had sex         Women only                                                             Men only 
 
8. Please indicate the number of sexual partners you’ve had in the last 3 months _____  
 
9. Please indicate the total number of sexual partners you’ve had in your lifetime _____ 
 
9.  During the last 3 months, have you used alcohol or drugs before or during sex? 
   0                    1         2         3         4         5         6         7         8         9         10  
Never had sex              Never                                                            Every time 
 
10.  Using the following scale, how would you feel about attending class with someone  
       who is HIV positive? 
1            2            3            4           5            6            7           8           9            10 
Uncomfortable                                                            Comfortable 
 
11.  Using the following scale, how would you feel about sharing a house, apartment, or  
       dorm room with someone who is HIV positive? 
1            2            3            4           5            6            7           8           9            10 
Uncomfortable               
Comfortable 
 
12.  Please list as many things as you can think of that would help protect you from  
       getting HIV. 
  
 1. 
 
 2. 
 
 3. 
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 4. 
 
 5. 
 
 
13.  Do you or your partner use condoms?  
   0                    1         2         3         4         5         6         7         8         9         10  
Never had sex                 Never                                                            Every time 
 
 
14.  When you use condoms, is it for:    _____ Contraception purposes 
     (Check all that apply)   _____ Protection against disease 
_____ Other (please list)   
   ____________________________ 
      _____ I never use condoms 
 
15.  When you do not use condoms, it is because:   _____ They’re uncomfortable 
       (Check all that apply)                                          _____ They decrease sexual  
pleasure  
       _____ They’re embarrassing to buy 
       _____ I don’t like them 
       _____ My partner doesn’t like them 
       _____ Other (please list)   
_____________________________ 
       _____________________________ 
         
16. What do you think is the likelihood of your being infected with HIV or AIDS if you  
      do not use condoms? 
      1             2             3             4            5            6            7           8            9         10 
 Not at all                                                                                                                             Definitely 
 
 
17.  Have you ever had an HIV test?       _____ Yes                     ______ No 
 
17a.  If you have been tested, how long has it been since you were tested 
          _____ Less than 1 year 
    _____ 1-2 years 
    _____ More than 2 years  
 
                       17b.  What caused or prompted you to get your HIV test? 
 
 
 
17c.  Did you get your HIV test results?    _____Yes    _____No 
 
17d.  If you did not get your test results, please indicate why: 
18.  What do you think are the advantages, if any, of getting an HIV test?   
 
 
71
       (list more on the back if needed) 
 1.  
 
 2.  
 
 3. 
 
19.  What do you think are the disadvantages, if any, of getting an HIV test?  
      (list more on the back if needed) 
 1. 
 
 2. 
 
 3. 
 
20.  Have you ever had or caused an unintended pregnancy   ______ Never 
          ______ 1-2 times 
          ______ More than twice 
 
 
21.  Have you been treated for a sexually transmitted infection? ______ Never 
                          ______ 1-2 times 
                       ______ More than twice 
 
 21a.  About how long ago were you treated?  ____________________________ 
 
 21b.  What infection(s) were you treated for?  ____________________________ 
 
22.   How many times did you see your doctor in the last 12 months?  _______________ 
   
23.   The last time you saw your doctor, was it for:  _______ Yearly/routine physical 
         (Check all that apply)    _______ Specific medical problem 
       _______ I had an injury 
       _______ School/work physical 
       _______ Prescription refill 
_______ I was sick 
                                        
24.   What amount of the time would you say that you wear a seat belt? 
      0           1            2           3            4            5           6           7          8          9         10 
    Never                                                                                                                                                                   Always  
 
 
25.  (FEMALE)  How often do you do a breast self exam? 
          1            2            3            4            5           6           7           8           9         10 
     Not at all                                                                                                                                         Every month 
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26.  (MALE)  How often do you do a testicle self exam? 
          1            2            3            4            5           6           7           8           9           10 
     Not at all                                                                                                                                                   Every month 
 
27.  I personally know someone who:  _____  is gay 
        (check all that apply)                    _____  is a lesbian 
       _____  is bisexual 
       _____  is HIV positive 
                      _____  has AIDS 
 
Please answer the next set of questions using the following scale:     
SA - Strongly Agree 
  A - Agree 
  N - Neither agree nor disagree 
  D - Disagree 
SD - Strongly Disagree 
 
28.  _______  I have discussed safer sex with my previous sex partner(s). 
 
29.  _______  I intend to discuss HIV testing with my future sex partner(s). 
 
30.  _______  My friends think it’s a good idea for me to practice safer sex. 
 
31.  _______  I think it’s a good idea to get an HIV test. 
 
32.  _______  I intend to discuss safer sex with my future sex partner(s). 
 
33.  _______  I have discussed HIV testing with my previous sex partner(s). 
 
34.  _______  Condoms help prevent the spread of HIV. 
 
35.  _______  My family thinks it’s a good idea for me to practice safer sex. 
 
36.  _______  I have discussed safer sex with my current sex partner(s). 
 
37.  _______  I intend to get an HIV test in the future.  
 
38.  _______  I have discussed HIV testing with my current sex partner(s). 
 
39.  _______  I think it’s a good idea to practice safer sex. 
 
40.  _______  I intend to practice safer sex in the future.  
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On the following questions, please check the appropriate answer: 
 
41.  If you have ever discussed HIV testing with a sex partner, who initiated the  
       conversation? 
_____  I brought it up 
_____  My partner brought it up 
_____  We both did after seeing or hearing something about it together 
_____  Someone else brought it up  
_____  I have never discussed HIV testing with my partner 
  _____  Other (please indicate)________________________________ 
      ________________________________________________________  
          
42.  I would discuss HIV testing with my sex partner(s), but 
 
  _____  I don’t know enough about it 
  _____  I don’t know what to say or how to get started  
    _____  I would be too embarrassed 
            _____  Other (please indicate)________________________________ 
      ________________________________________________________  
 
43.  If you have ever discussed safer sex with a sex partner, who initiated the 
conversation? 
 
_____  I brought it up 
_____  My partner brought it up 
_____  We both did after seeing or hearing something about it together 
_____  Someone else brought it up  
_____  I have never discussed safer sex with my partner 
  _____  Other (please indicate)__________________________________ 
__________________________________________________________ 
  
44.  I would discuss safer sex with my sex partner(s), but: 
 
  _____  I don’t know enough about it 
  _____  I don’t know what to say or how to get started 
  _____  I would be too embarrassed 
      _____  Other (please indicate)__________________________________ 
  __________________________________________________________  
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Appendix E.  Self-protective behavior information gathered in Phase 2 
 
SES 
 
Please use the following scale to respond to the statements: 
 
SA:  Strongly Agree 
  A:   Agree 
  N:   Neither agree nor disagree 
  D:   Disagree 
SD:   Strongly Disagree 
 
_______  1. I have discussed safer sex with my past sex partner(s). 
_______  2. I have discussed safer sex with my future sex partner(s). 
_______  3. I have discussed safer sex with my current sex partner(s). 
_______  4. My friends think it is a good idea to use safer sex. 
_______  5. I think it’s a good idea to get an HIV test. 
_______  6. I have discussed HIV testing with my past sex partner(s). 
_______  7. I have discussed HIV testing with my future sex partner(s). 
_______  8. I have discussed HIV testing with my current sex partner(s). 
_______  9. Condoms help prevent the spread of HIV. 
_______ 10. My family thinks it is a good idea to use safer sex. 
_______ 11. I plan to get an HIV test in the future. 
_______ 12. I think it is a good idea to use safer sex. 
_______ 13. I plan to practice safer sex in the future. 
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Appendix F.  AIDS Health Belief Scale 
 
AHBS 
 
Please use the following scale to respond to the statements.       
 
   SA:  Strongly Agree 
  A:  Agree 
  N:  Neither Agree nor Disagree 
  D:  Disagree 
            SD:  Strongly Disagree 
 
_______  1.  I feel that the chances are good that I can get AIDS 
_______  2.  I am afraid that I might contract AIDS. 
_______  3.  I believe that I van be exposed to HIV infection if my sex partner is  
                     heterosexual. 
_______  4.  I believe that I can get AIDS even if I am only having sex with one  
                     partner. 
_______  5.  AIDS causes death. 
_______  6.  I would rather have any other terminal illness than AIDS. 
_______  7.  I would rather die from a violent death (e.g., gunshot, car accident,  
                     etc) than from AIDS. 
_______  8.  AIDS is probably the worst disease a person can get. 
_______  9.  I believe that the chances of contracting AIDS can be significantly  
                     reduced by using a condom. 
_______ 10.  I think it is worth the effort to have condom readily available. 
 
_______  11.  I feel that the chances of contracting AIDS can be reduced by  
                       having sex with only  one partner. 
_______  12.  If a condom is not available, it would be worth the effort to  
           discontinue sexual activity to obtain a condom. 
_______  13.  Using a condom seems like an insult to my partner. 
_______  14.  It is embarrassing (to me) to buy condoms. 
_______  15.  I do not enjoy (or think I might not enjoy) sex when using a  
                       condom. 
_______  16.  I would offer first-aid to an AIDS patient because I would feel guilty  
           of not offering to help.                           
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Appendix G.  Health Locus of Control Scale 
 
HLOC 
 
Please enter the degree to which you agree or disagree with each statement using the 
following code: 
 
SA = Strongly agree 
   A = Agree 
MA = Minimally agree 
MD = Minimally disagree 
   D = Disagree 
SD = Strongly disagree 
 
  
        ____ 1.  If I take care of myself, I can avoid illness. 
 
        ____ 2.  Whenever I get sick it is because of something I’ve done or 
not done. 
  
        ____ 3.  Good health is largely a matter of good fortune.  
 
        ____ 4.  No matter what I do, if I am going to get sick I will get sick.  
 
        ____ 5.  Most people do not realize the extent to which their illnesses 
are controlled by accidental happenings. 
 
        ____ 6.  I can only do what my doctor tells me to do.  
 
        ____ 7.  There are so many strange diseases around that you can 
never know how or when you might pick up one.  
 
       ____ 8.  When I feel ill, I know it is because I have not been getting 
the proper exercise or eating right.  
 
        ____ 9.  People who never get sick are just plain lucky.  
 
        ____ 10.  People’s ill health results from their own carelessness.  
 
        ____ 11.  I am directly responsible for my health.  
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Appendix H.  Social Desirability Scale 
 
SD 
 
Listed below are a number of statements concerning personal attitudes and traits.  Read 
each item and decide whether the statement is true or false as it pertains to you. 
 
T     F     1. Before voting I thoroughly investigate the qualities of all candidates. 
 
T     F     2. I never hesitate to go out of my way to help someone in trouble. 
 
T     F     3. It is sometimes hard for me to go on with my work if I am not encouraged. 
 
T     F     4. I have never intensely disliked anyone. 
 
T     F    5. On occasions, I have had doubts about my ability to succeed in life. 
 
T     F     6. I sometimes feel resentful when I don’t get my way. 
 
T     F     7. I am always careful about my manner of dress. 
 
T     F     8. My table manners at home are as good as when I eat out in a restaurant. 
 
T     F     9. If I could get into a movie without paying and be sure I was not seen, I would  
       probably not do it.              
 
T     F   10. On a few occasions, I have given up doing something because I thought too  
                   little of my ability.                 
 
T     F   11. I like to gossip at times. 
 
T     F   12. There have been times when I have felt like rebelling against people in  
       authority, even though, I knew they were right. 
 
T     F   13. No matter whom I’m talking to, I’m always a good listener. 
 
T     F   14. I can remember “playing sick” to get out of something. 
 
T     F   15. There have been occasions when I took advantage of someone. 
 
T     F   16. I am always willing to admit it when I make a mistake. 
 
T     F   17. I always try to practice what I preach. 
 
 
T     F   18. I don’t find it particularly difficult to get along with loudmouth, obnoxious  
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       people. 
 
T     F   19. I sometimes try to get even rather than forgive and forget. 
 
T     F   20. When I don’t know something, I don’t mind at all admitting it. 
 
T     F   21. I am always courteous, even to people who are disagreeable. 
 
T     F   22. At times I have really insisted on having things my own way. 
 
T     F   23. There have been occasions when I felt like smashing things. 
 
T     F   24. I would never think of letting someone else be punished for my wrongdoings. 
 
T     F   25. I never resent being asked to return a favor. 
 
T     F   26. I have never been irked when people expressed ideas very different from my  
                   own. 
 
T     F   27. I never make a long trip without checking the safety of my car. 
 
T     F   28. There have been times when I was quite jealous of the good fortune of others. 
 
T     F   29. I have almost never felt the urge to tell someone off. 
 
T     F   30. I am sometimes irritated by people who ask favors of me. 
 
T     F   31. I have never felt that I was punished without cause. 
 
T     F   32. I sometimes think when people have a misfortune they only got what they  
       deserved. 
 
T     F   33. I have never deliberately said something that hurt someone’s feelings.   
 
 
